Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
CACNA1G	Cav3.1, NBR13	ENSG00000006283	Calcium voltage-gated channel subunit alpha1 G	O43497	17	50561068-50627474	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel	Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.8;cervix, uterine: 13.6	Cell type enriched	Detected in some	26	Bipolar cells: 147.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 13.4;GAMG: 5.0;HeLa: 4.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004714	Uncertain											HPA004714: AB_1078368	unprognostic (1.90e-2)	unprognostic (5.83e-2)	unprognostic (2.85e-2)	unprognostic (1.08e-1)	unprognostic (4.00e-1)	unprognostic (9.89e-2)	unprognostic (1.47e-2)	unprognostic (2.73e-1)	unprognostic (1.02e-4)	unprognostic (1.47e-2)	unprognostic (2.16e-2)	unprognostic (9.76e-2)	unprognostic (4.87e-12)	unprognostic (3.34e-2)	unprognostic (1.62e-1)	unprognostic (1.56e-3)	unprognostic (6.63e-2)	1.7	1	3.5	0.9	5.2	1.3	2.1	22.8	17.1	13.6	1	2.7	0	0.9	7.4	1	1.6	5.7	1.2	3.8	2.4	8.8	0.7	1.1	0.9	1.2	5.3	7.9	7.1	0.6	0.6	0.4	1.4	6.1	2.5	0.8	4.3	1.1	1.6	0.8	3.9	0.8	2.1	5.9	0.9	0.9	1.7	2.3	0	1.2	0	1	1	3.9	1.3	1.3	2.7	0.8	0.7	1.4	0	0	13.4	3.1	3.5	0.9	0.1	0.2	0.1	0	0.1	0.2	2.8	0.5	0	1	0.1	5	0.5	1.6	0	0.3	1.8	0.6	0.9	4.6	0.7	0.1	0.2	0.3	0.1	0	0	0	0.8	0	0.1	0	0.2	0.1	0.7	0	0	1.2	1	0.8	1.4	1.1	0	0	0.2	4.1	1.8	2.8	0.1	0	2.4	0.2	0.1	0.3	1.4	3.9	0.5	0.1	1	0.1	0	0.6	0.1	0.5	0.5	0.8	0.6	1.4	0.4	0.7	0.8	0.7	0.8	0.2	1.3	0.9	1	2.7	0.7	0.4	1.3	0.5	0	3.5	5.2	22.8	17.1	2.4	8.8	5.3	7.9	6.1	2.3	0	0	0	0.1	1.6	147.6	4.1	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.3	3.6	0.4	0	0	0.4	4.8	0	0	0	0	0	0	3.3	0	0	1.8	0	0	0	0	5.7	0	3.6	0.3	0.2	2.5	0.1	0	0	0	Bipolar cells
GABRA1	EJM5	ENSG00000022355	Gamma-aminobutyric acid type A receptor alpha1 subunit	P14867	5	161847063-161899981	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	22	brain: 58.6	Cell type enriched	Detected in some	24	Bipolar cells: 209.5	Cancer enriched	Detected in single	5	glioma: 1.1	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022502, HPA029363, HPA055746	Enhanced	Supported	Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	CAB022502: , HPA029363: , HPA055746: AB_2682904					unprognostic (2.58e-2)						unprognostic (4.78e-3)	unprognostic (1.84e-1)		unprognostic (3.31e-1)		unprognostic (2.43e-1)		1	2.6	8.5	1	21.9	1	1	35.2	58.6	1	1	1.8	0	1.1	1	1	1	1	1	1	10.5	8.8	1	1	1	1	6.7	22	1	1	1	0.1	1	7.4	1.2	1	0.2	1	1.1	1	1	1	1	1.3	1.1	1.5	1.1	0	0	1	0	1.3	1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	3.7	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0.9	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	1.6	0.1	0	0.1	0	0	2.3	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.5	21.9	35.2	49.8	10.5	8.8	6.7	22	7.4	0	0	0	0	0	0	209.5	0.5	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0.2	0	0	0	7.9	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0	Bipolar cells
CAMK2B	CAM2, CAMK2, CAMKB	ENSG00000058404	Calcium/calmodulin dependent protein kinase II beta	Q13554	7	44217150-44334577	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Neurogenesis	Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7	Cell type enriched	Detected in many	11	Bipolar cells: 838.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	8	SCLC-21H: 42.0	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB006849, HPA026307, HPA051783, HPA051785, HPA053973	Enhanced	Supported	Supported	Plasma membrane,Cell Junctions,Cytosol					680000	Plasma membrane	Cell Junctions, Cytosol	CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328	unprognostic (1.88e-3)	unprognostic (4.49e-2)	unprognostic (3.55e-3)	unprognostic (1.36e-2)	unprognostic (5.25e-2)	unprognostic (2.90e-2)	unprognostic (8.78e-2)	unprognostic (1.09e-1)	unprognostic (1.44e-1)	unprognostic (2.71e-1)	unprognostic (1.17e-2)	unprognostic (1.60e-2)	unprognostic (5.23e-7)	unprognostic (7.04e-2)	unprognostic (2.34e-1)	unprognostic (3.15e-2)	unprognostic (3.95e-2)	1.4	8.1	20.6	1.4	46.7	1.2	2	60.1	81.9	1.2	1.4	4	0.7	1.7	1.3	18.8	2	1.8	1.2	39.2	36.5	18	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0	7.7	2.4	2	1.1	0	1.3	1	3.2	1.2	3.2	1.2	0.8	0	0.3	0.2	0.3	0	0.2	0.2	0.1	0	0.1	0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0	1.1	2.4	0	0.1	0.1	0	0	0.5	0	0	0	0.3	0.1	0	0	0	0.4	0	5.3	0	0.2	0.1	0	2.4	0.1	0.9	0.1	0	0	42	2.2	0.2	0	0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0	0.5	0.4	0.1	0.2	0	0.2	3.2	0.7	1	0.8	0.9	1.2	1.1	1	0.5	0.5	1.3	1.2	1.1	2	3.2	1.2	1	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18	10.3	21.3	13.4	4.8	0	0	0	27.8	1	838.1	74.9	2.5	0	0	0	43.2	0	8.3	0	0.8	0.6	0	0	0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39	0	1.2	2.1	1.7	0	1.7	0	0	14.1	0.1	0	0	0.8	46.7	0	0.9	0	1.7	0.4	0.2	0	0	0.7	Bipolar cells
CACNA1I	Cav3.3	ENSG00000100346	Calcium voltage-gated channel subunit alpha1 I	Q9P0X4	22	39570753-39689737	FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1	Cell type enriched	Detected in some	6	Bipolar cells: 18.4	Cancer enhanced	Detected in single		thyroid cancer: 2.1					Cell type enhanced	Detected in some		naive CD4 T-cell: 1.9	Lineage enriched	Detected in single	20	T-cells: 1.9	Cell line enhanced	Detected in some		JURKAT: 1.2;SK-BR-3: 6.1;T-47d: 3.6	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (3.97e-2)	unprognostic (1.42e-1)	unprognostic (1.02e-1)	unprognostic (4.60e-2)	unprognostic (3.52e-2)	unprognostic (1.58e-1)	unprognostic (1.19e-1)	unprognostic (2.63e-1)	unprognostic (7.21e-2)	unprognostic (5.20e-3)	unprognostic (1.64e-2)	unprognostic (8.64e-2)	unprognostic (1.62e-2)	unprognostic (6.14e-3)	unprognostic (1.57e-1)	unprognostic (3.78e-2)	unprognostic (8.27e-4)	0	4.6	3.4	1.9	5.8	1.3	0.2	8.1	7.5	0	0.2			0.2	0	0	0.1	0	0.4	0	5	3.6	0	0	0.2	4.3	0.7		0	0	0	0	0		0	0.1		0	0	0	0.1	0.9	0	0.4	1.3	0.5	1.1			4.1		1.2	0.6	0	0	0	0	0	0	1.9	0.1	0	0.1	0	0	0	0	0.5	0	0	0.1	0.1	0	0	0	0	0	0.8	0	0.1	0	0	0.4	0	0.1	0	0	0	0	1	0	0	0	0	0.2	0	1.2	0	0	0	0.8	0	0	0.1	0.3	0	0	0	0.3	0	0.1	0.2	0	0	6.1	0	0.4	3.6	0	0	0	0.8	0	0	0.2	0	0	0	0.5	0	0	0	0	0	0	0.3	0	1.2	0.5	0	0	1.9	0.7	0	0	0	0	0.8	0.1											0	0	0	0	0	18.4	2.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0.3	0	0	0	0	0	0	2.1	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	Bipolar cells
SLC8A3	NCX3	ENSG00000100678	Solute carrier family 8 member A3	P57103	14	70044217-70189070	Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sodium transport, Transport	Calmodulin-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 17.0;skeletal muscle: 32.1	Cell type enriched	Detected in some	4	Bipolar cells: 33.9	Cancer enriched	Detected in single	8	glioma: 1.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 4.0;LHCN-M2: 7.3;SH-SY5Y: 23.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.65e-1)	unprognostic (5.53e-2)	unprognostic (1.18e-2)	unprognostic (1.51e-2)	unprognostic (2.41e-1)	unprognostic (1.95e-1)	unprognostic (1.69e-1)	unprognostic (3.46e-3)	unprognostic (4.74e-2)	unprognostic (1.64e-1)	unprognostic (1.45e-3)	unprognostic (8.53e-2)	unprognostic (5.86e-2)	unprognostic (1.14e-3)	unprognostic (1.48e-1)	unprognostic (1.48e-1)	unprognostic (3.38e-1)	0.7	2.8	6.1	1.2	6.1	1	0.9	3.8	17	1.4	1.1	3.1	0	1.1	0.9	1	1.1	0.7	1.3	1.5	5.8	8.2	0.6	0.6	1.6	1	4.7	7.1	0.6	1	0.6	1.5	0.7	6.4	1.2	1.1	1.5	0.6	0.8	32.1	0.8	1.2	1.2	2.8	0.7	1.2	0.8	1.9	0	0.6	4.9	0.9	1	0.3	0	0	0	0	0	0	0.7	0	0	4	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	1.8	0	0	0	0	23.9	0.1	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	6.1	6.1	3.8	10.6	5.8	8.2	4.7	7.1	6.4	1.9	0	1.1	0	0	0.1	33.9	1.1	0	0	0	0	3.9	0	0	0	0.3	0	0	0	0	0.1	0.2	0	8.1	0	0.1	7.9	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	1	0	0	0	0	0	0	0	0	0	Bipolar cells
VSX1	PPCD, PPCD1, PPD	ENSG00000100987	Visual system homeobox 1	Q9NZR4	20	25070885-25082365	Disease related genes, Predicted intracellular proteins, Transcription factors	Sensory transduction, Transcription, Transcription regulation, Vision	Developmental protein, DNA-binding	Corneal dystrophy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	brain: 17.0;retina: 20.7	Cell type enriched	Detected in some	20	Bipolar cells: 345.7	Not detected	Not detected			Region enriched	Detected in many	7	cerebellum: 17.0	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	5	Karpas-707: 9.9	Not detected	Not detected			Not detected	Not detected																unprognostic (1.93e-1)	unprognostic (6.63e-2)		unprognostic (9.68e-3)	unprognostic (4.33e-2)		unprognostic (2.27e-1)	unprognostic (1.97e-1)	unprognostic (4.01e-1)	unprognostic (8.64e-3)	unprognostic (2.70e-2)	unprognostic (1.35e-1)	unprognostic (2.31e-9)	unprognostic (1.53e-2)	unprognostic (2.35e-1)	unprognostic (3.07e-4)	unprognostic (2.38e-1)	0.4	3	2.3	0.4	1.6	1.6	0.4	17	2.8	0.4	0.4	0.4	0.4	0.1	1	0.4	0.4	0.4	0.4	0.5	1.9	2.1	0.4	0.4	0.4	0.4	2.1	0.4	4.6	1.2	1.1	2.7	0.4	0.5	0.5	0.1	20.7	0.4	1	1	0.6	0.5	0.4	1.5	0.4	0.3	0.7	0.4	0.4	0.7	0.4	0.4	0.4	0.4	1	1.5	2.4	0.3	1.3	0.6	0.1	0.1	1.5	0.2	0.2	0	0	0.2	0	0	0	0	0	0.2	0.2	0.2	0	1.8	0.2	0	0	0	0.3	0.2	0.1	0.4	0.3	0	0.3	0.1	0	0	0.1	0	0.2	0	0.9	0	9.9	0	0.2	0	0	0.1	0	0.3	0.1	0.1	0	0	0.2	0.5	0.1	0	0.3	0	0.2	0.8	0.3	0.1	0.3	0	0.1	0	0.3	0	0.3	1	0.1	0.1	2.4	0.3	0.3	0.6	0.3	0.5	0.7	0.4	0.3	0	1	0.4	0.5	2.1	1.3	0.2	1.5	0.1	0.1	2.3	1.6	17	1.4	1.9	2.1	2.1	0.4	0.5	0.4	0	0	0	0	0	345.7	1.2	0	0	0	0	3.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0.3	0	0	0	0	4.3	0.1	0	0	0	16.9	0	0	0.1	0.5	0	0	0	0	0	Bipolar cells
GABRR2		ENSG00000111886	Gamma-aminobutyric acid type A receptor rho2 subunit	P28476	6	89257208-89315299	FDA approved drug targets, Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	12	retina: 18.8	Cell type enriched	Detected in some	13	Bipolar cells: 19.8	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		plasmacytoid DC: 1.0	Lineage enhanced	Detected in single		dendritic cells: 1.0	Cell line enhanced	Detected in some		U-266/70: 4.4;U-266/84: 1.6	Low region specificity	Detected in single			Low region specificity	Detected in many																unprognostic (2.05e-2)	unprognostic (1.47e-4)	unprognostic (1.56e-1)	unprognostic (1.88e-4)	unprognostic (4.19e-1)	unprognostic (1.07e-1)	unprognostic (2.24e-2)	unprognostic (9.13e-2)	unprognostic (2.87e-1)	unprognostic (1.10e-2)	unprognostic (2.65e-1)	unprognostic (1.41e-1)	unprognostic (1.54e-6)	unprognostic (3.69e-2)	unprognostic (7.81e-2)	unprognostic (5.79e-2)	unprognostic (7.15e-3)	0.2	0.6	0.2	0.5	0.4	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0	0.7	0.5	0.2	0.1	0.4	0.2	0.3	0.2	0.3	0.4	0.1	0.9	0.3	0.1	0.1	0.8	0	0.2	0.1	0.1	0.3	0	18.8	0.6	0.2	1.5	0.5	0.1	0.1	0.2	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.3	1	0	0	0	0.1	0.1	0	0.6	0	0.4	0.5	0	0	0	0.1	0	0.2	0	0.3	0.6	0.3	0.2	0.1	0.1	0	0	0.1	0	0.4	0.3	0	0	0.2	0	0	0.2	0.1	0	0	0	0	0.2	0.1	0.6	0	0.2	0.2	0	0	0	0.2	0.9	0.4	0	0.3	0.1	0	0	0	0.1	0	0	0.1	1	0	0.4	0	0	0	4.4	1.6	0	0.5	0.4	0.3	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	1	0	0.1	0.2	0.4	0.3	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0	0	0	0	0	19.8	0.3	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	Bipolar cells
GRM6	CSNB1B, GPRC1F, mGlu6, MGLUR6	ENSG00000113262	Glutamate metabotropic receptor 6	O15303	5	178978327-178996206	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Receptor, Transducer	Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	retina: 22.0	Cell type enriched	Detected in some	31	Bipolar cells: 422.6	Not detected	Not detected			Low region specificity	Detected in some			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			HPA014511	Enhanced											HPA014511: AB_2669025	unprognostic (1.85e-1)	unprognostic (1.54e-1)	unprognostic (8.41e-2)	unprognostic (1.27e-1)	unprognostic (4.16e-1)	unprognostic (2.25e-3)	unprognostic (7.72e-2)	unprognostic (2.32e-2)	unprognostic (2.12e-3)	unprognostic (6.27e-2)	unprognostic (3.34e-4)	unprognostic (2.58e-1)	unprognostic (3.36e-4)	unprognostic (1.23e-1)	unprognostic (6.45e-2)	unprognostic (7.59e-3)	unprognostic (1.97e-1)	0.3	0.5	0.6	0.4	0.6	1.6	0.3	1.9	1.6	0.4	0.4	0.3	0.3	0.3	0.6	0.5	0.3	0.5	0.7	0.4	0.5	1.2	0.4	0.4	0.4	0.5	0.8	0.3	0.7	0.9	0.1	2.9	0.3	1.2	1.1	0.1	22	0.6	0.3	1.3	1.8	0.3	0.3	0.3	0.5	0.3	2.2	0.3	0.3	0.9	0.3	0.3	0.3	0.3	0.9	1.1	2.4	0.4	0.6	0.6	0.1	0.5	0.3	0.7	1.3	0.3	0.1	0.7	0.2	0	0.1	0	0.5	0.9	0.9	0.6	0	0.6	0.7	0	0.1	0	0.2	0.7	0.5	0.7	1	0.2	0.8	1	0.1	0.3	0.1	0.5	0.3	0	0.9	0.9	1.7	0	1	0.2	0.8	0.6	0.5	0.6	0.6	0.3	0.8	0.1	0.6	0.9	1.2	0.5	0.7	0.5	1.1	0.9	1.1	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.4	0.4	0.7	0.3	1.9	0.4	0.5	0.6	0.3	0.4	0.4	0.4	0.3	0.2	0.9	0.4	0.4	2.4	0.6	0.2	1.1	0.2	0.1	0.6	0.6	1.9	0.5	0.5	1.2	0.8	0.3	1.2	0.3	0	0.3	0	0.1	0.3	422.6	1.4	0	0	0	0	2	0	0	0	0.8	0.5	0	0	0	0	0	0.3	0	0	0.1	3.2	0	0	0	0.9	0	0.2	0	1	0	3.7	0.1	0	0	0	13.7	0	0	0.5	0	0	0.1	0	0	0.1	Bipolar cells
GABRG2		ENSG00000113327	Gamma-aminobutyric acid type A receptor gamma2 subunit	P18507	5	162000057-162162977	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	brain: 47.1	Cell type enriched	Detected in some	4	Bipolar cells: 81.7	Cancer enhanced	Detected in single		glioma: 1.4	Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 7.3	Group enriched	Detected in many	5	B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2	Cell line enhanced	Detected in many		CACO-2: 10.6;RPMI-8226: 10.2;SuSa: 11.4;U-266/70: 17.8;U-266/84: 14.1	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB079060		Supported										CAB079060: 					unprognostic (2.88e-2)			unprognostic (1.56e-2)			unprognostic (6.31e-3)			unprognostic (3.07e-3)	unprognostic (1.52e-1)			1.1	5.7	9.7	1.2	28.8	3.3	0.9	21.7	47.1	0.7	1.5	1.1	0	2.2	1.2	1.3	1.3	1.3	3.8	1.6	10.6	19.6	1	1.2	1.9	1.2	7.5	19.1	1.5	1	0.8	5.3	2.9	17.6	1	1.3	0.6	1.3	0.8	1.2	3.3	1.9	1.6	2.6	1.2	3.3	1.7	1.8	0	1.8	0	1.3	1.5	0.3	2.9	0.7	7.3	0.3	0.9	3.2	0.2	3.6	1.7	1.9	0.3	0	0	2	0.6	0	0	0	10.6	4.7	0.7	5.2	0	0.4	1.6	1.2	0	0	0.8	1.1	0	2.1	1.3	0	0.2	0.5	0.3	0	0	0	0.5	0	1	1.8	8.5	0	2.5	0.4	0.1	6.1	3.4	2.9	0.4	0.1	10.2	0	3.4	0.9	0.8	0.3	0.6	3.4	11.4	5.6	5.7	0.2	0.3	4.5	0.3	0.5	17.8	14.1	0.5	0.2	0.4	0.4	7.3	0.3	0.6	0.4	0.3	2.7	2.9	0.7	0.6	0	2.5	3.2	0.7	1.6	0.9	0.2	0.7	0.6	0.2	9.7	28.8	21.7	38.1	10.6	19.6	7.5	19.1	17.6	1.8	17.9	19.7	0	0	0	81.7	0.2	0	12	19.4	0	11.8	0	0	0	0	0	0	0	0	0	0	0	8.1	0	0.1	15.9	0	0	0	0	0	0	0	0	0	1.4	0.1	0	0	0	8.4	0	0	0	1.1	0	0	0	0	0	Bipolar cells
IGSF21	MGC15730, RP11-121A23.1	ENSG00000117154	Immunoglobin superfamily member 21	Q96ID5	1	18107746-18378483	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 48.5;lymphoid tissue: 16.5	Cell type enriched	Detected in some	17	Bipolar cells: 179.6	Group enriched	Detected in many	5	breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SCLC-21H: 20.3	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane				7900				unprognostic (1.87e-1)	unprognostic (1.73e-1)	unprognostic (1.50e-3)	unprognostic (7.06e-2)	unprognostic (3.29e-1)	unprognostic (1.01e-1)	unprognostic (1.45e-1)	unprognostic (1.66e-2)	unprognostic (7.87e-2)	unprognostic (2.77e-3)	unprognostic (4.34e-2)	unprognostic (2.33e-1)	unprognostic (7.85e-4)	unprognostic (3.76e-5)	unprognostic (2.10e-1)	unprognostic (1.23e-2)	unprognostic (2.63e-2)	3.1	9	14.1	1.7	12.3	1.6	6	48.5	32.7	3	1.8	7.2	0	0.9	1.9	1.8	2.6	1.8	2.4	1.8	21.1	10.4	1.7	1.7	2.5	1.3	10.9	13.9	2	4.1	1.8	1.1	3.3	10.1	4.5	1.5	5.5	1.9	3	1.4	1.5	1.2	2.7	6.5	16.5	1.6	1.8	4.5	0	1.4	0	2.1	4.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.1	12.3	48.5	27.4	21.1	10.4	10.9	13.9	10.1	4.5	0	0	0.9	0	0.2	179.6	0.4	2.5	0	0	0	0	0	0	0	4	0	0	0	0	0	0	1.2	0	0	0.6	1.6	2.9	0	10.5	8.3	0.6	1.6	0	0	0	3.7	0.2	0.6	0	0	10.8	6.5	0.3	0.2	0.4	0.1	0	0	0	0.1	Bipolar cells
SLC8A2	KIAA1087, NCX2	ENSG00000118160	Solute carrier family 8 member A2	Q9UPR5	19	47428017-47472168	Plasma proteins, Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sodium transport, Transport	Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 50.9	Cell type enriched	Detected in some	8	Bipolar cells: 16.2	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1	Group enriched	Detected in many	4	amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1	Low region specificity	Detected in all			HPA050818, HPA054671	Enhanced											HPA050818: AB_2681248, HPA054671: AB_2682568	unprognostic (3.75e-2)	unprognostic (1.84e-1)	unprognostic (1.42e-1)	unprognostic (4.32e-2)	unprognostic (1.34e-1)	unprognostic (6.00e-3)	unprognostic (1.38e-1)	unprognostic (2.79e-1)	unprognostic (1.34e-1)	unprognostic (8.95e-2)	unprognostic (4.77e-2)	unprognostic (2.04e-2)	unprognostic (2.81e-3)	unprognostic (6.13e-2)	unprognostic (9.40e-2)	unprognostic (1.53e-1)	unprognostic (1.63e-2)	1.2	4	16.6	1	18.1	0.9	0.9	50.9	50.7	1	2.4	1.8	1	1.3	5.4	1	2.3	2.2	1.1	0.9	21.4	6.8	1	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1	2	1.4	1.4	0	1.2	4.4	0.9	1	1.2	5.5	2	1	1.3	1.9	1.2	0	1	0	0.9	1.2	0.4	0	0	0	0	0	0.3	0	0	0.5	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0	0.4	0.2	0	0	0	0	0.1	0	0	0	0	0	1.2	0	0.2	0	0	0.1	0	0.1	0.2	0.1	0	0	0	0.1	4.4	0.6	0	0	0	0	0.4	0.1	12.5	6.7	5.2	0.6	0.4	0.4	0.2	0	0	0	8.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2	1.2	0	0	0	0.1	0	16.2	1.4	0	0	0	0	2	0	0	0.3	1.6	0	0	0	0	0	0	0.1	0	0	0.1	0	1.7	0	0	0.2	0	0	0	0	0	0.3	0.5	0	0	0	0.9	0	0.3	1.1	1.7	0	0.1	0	0	0.1	Bipolar cells
OLFM3	NOE3	ENSG00000118733	Olfactomedin 3	Q96PB7	1	101802574-101997030	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 30.0	Cell type enriched	Detected in some	5	Bipolar cells: 25.0	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA050297			Uncertain	Vesicles	Secreted in brain					Vesicles		HPA050297: 			unprognostic (4.19e-1)	unprognostic (4.19e-4)	unprognostic (1.26e-1)				unprognostic (4.61e-2)	unprognostic (2.93e-1)	unprognostic (1.47e-2)			unprognostic (3.58e-4)	unprognostic (2.48e-1)	unprognostic (5.68e-2)		0.7	3.2	5	1.4	13.7	0.7	0.8	24.2	30	0.9	1.8	0.4	0	1	0.9	1.2	0.7	0.8	0.8	0.7	4.8	7.4	1.5	0.8	0.7	0.7	6	11.9	0.8	0.7	0.7	2.4	0.8	16.6	0.7	1.7	0.3	0.8	0.7	0.7	0.7	2.1	1.3	1.5	0.9	1	0.9	0.7	0	1.2	0	0.7	0.7	0.1	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.6	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0.5	0.3	0	0	3.8	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	13.7	24.2	26.7	4.8	7.4	6	11.9	16.6	0.7	0	0	0	0	0	25	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	Bipolar cells
NEUROD4	ATH-3, Atoh3, bHLHa4, MATH-3	ENSG00000123307	Neuronal differentiation 4	Q9HD90	12	55019945-55030014	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	pituitary gland: 54.8	Cell type enriched	Detected in some	16	Bipolar cells: 170.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	AF22: 3.7;SCLC-21H: 7.7	Not detected	Not detected			Not detected	Not detected			HPA015545	Enhanced											HPA015545: AB_2669215					unprognostic (1.78e-2)													0	7	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	54.8	0	0.7	0	0	9.5	0	0	0	0	0	0	0.2	0	0	1.1	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	3.7	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.9	7.7	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0.7	0	0	0	0	0	0	170.1	2	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	Bipolar cells
KIRREL2	DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1	ENSG00000126259	Kirre like nephrin family adhesion molecule 2	Q6UWL6	19	35855861-35867109	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	pancreas: 38.5	Cell type enriched	Detected in some	4	Bipolar cells: 27.4	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Cell type enhanced	Detected in single		memory CD8 T-cell: 1.3	Lineage enriched	Detected in single	5	T-cells: 1.3	Cell line enhanced	Detected in some		HDLM-2: 15.1;HMC-1: 24.4;JURKAT: 14.1;U-937: 5.4	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA071587, HPA074326	Enhanced		Supported	Centriolar satellite	Intracellular and membrane					Centriolar satellite		HPA071587: AB_2732182, HPA074326: AB_2732251	unprognostic (1.28e-2)	unprognostic (1.80e-1)	unprognostic (3.29e-2)	unprognostic (3.16e-3)	unprognostic (2.05e-3)	unprognostic (2.29e-1)	unprognostic (2.00e-1)	unprognostic (1.72e-3)	unprognostic (3.30e-2)	unprognostic (5.56e-2)	unprognostic (4.85e-2)	unprognostic (2.62e-2)	unprognostic (2.43e-6)	unprognostic (1.72e-1)	unprognostic (4.44e-1)	unprognostic (1.48e-2)	unprognostic (2.62e-2)	0.2	0	0.4	0.3	0.8	0	0	0.2	1.2	0.1	0	0.1	0	0.1	0	0	0.1	0	0	0	0.7	0	0.4	0	0	0.5	0.2	0.4	0	38.5	0	0.9	0.1	0.5	0	0.1	2.1	0	0	0	0	0	0	0.1	0	0.4	0.3	0.2	0.5	0	0	0.4	0	0	0	0	0	0	0.2	1.3	0	0	0.4	0.8	0	0	0	1.2	0	0	0.1	0	0.7	0.5	0	0.1	0	2.6	0.1	2.1	0	0	15.1	0	0	0	0.2	0	0	24.4	0.1	0	0	0	0	0	14.1	0.1	0.2	0	0.1	0.4	0	0.1	0	0	3.9	0	0	0	0	3	0.9	0	0	0	0.1	0	3.8	0	0.6	1	0.2	0	0	0	0.2	0	5.4	0.5	0	0	0	0.1	0	0	0	0.2	1.3	0	0	0.2	0.9	0	0.2	0	0	0	0	0.4	0.8	0.2	1.2	0.7	0	0.2	0.4	0.5	0.2	0	0	0	0	0	27.4	0.6	0	0	0	0	0	0	1.7	0	1.3	0	0	0	5.3	0.1	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0.9	6.8	0	0	0	2.9	0	0	0.7	0.9	0	0	0	0	0	Bipolar cells
GNG13	G(gamma)13, h2-35	ENSG00000127588	G protein subunit gamma 13	Q9P2W3	16	798041-800733	Predicted intracellular proteins, RAS pathway related proteins		Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	brain: 78.6;retina: 22.9	Cell type enriched	Detected in some	20	Bipolar cells: 323.3	Low cancer specificity	Detected in some			Region enriched	Detected in many	7	cerebellum: 78.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		CACO-2: 11.2;HEK 293: 9.9;HeLa: 5.9;MCF7: 13.9	Region enhanced	Detected in all		cerebellum: 1054.1	Group enriched	Detected in many	6	cerebellum: 43.5;olfactory region: 18.2	HPA046272	Enhanced											HPA046272: AB_10960062	unprognostic (1.84e-1)	unprognostic (2.75e-1)	unprognostic (3.78e-2)	unprognostic (2.48e-1)	unprognostic (2.57e-2)	unprognostic (5.41e-2)		unprognostic (8.47e-2)	unprognostic (9.16e-3)	unprognostic (4.04e-2)	unprognostic (1.78e-1)	unprognostic (6.77e-2)		unprognostic (7.12e-2)	unprognostic (1.55e-1)		unprognostic (3.38e-1)	0.2	0.2	1.8	0.7	3.3	0.9	0.3	78.6	11.3	0.2	2.9	3.4	0	5.4	0.2	0.7	0.2	0.2	0.3	0.2	1.1	1.6	0.2	0.2	0.3	0.6	1.3	2.7	0.3	0.2	0.2	0.3	0.4	2.7	0.4	0.6	22.9	0.2	0.2	0.2	0.5	5.1	0.4	1.9	0.4	0.8	1.5	0.2	0.2	0.3	0	0.6	0.2	0.1	0	0	0	0	0	0	0	0.2	3.9	0.5	1.2	0	0	0.9	1	0	0	0	11.2	0.3	1.2	0.3	0	0.1	1.7	0	0	0	1.3	9.9	1.4	5.9	0	0	2.3	0.4	0	0	0	0	0	0	1.3	1.9	0.9	0	13.9	1.3	0.8	1.3	0.1	1.2	3	3.2	0.7	0	1.7	1	0.9	1	0.4	0.2	0.4	0.8	0.1	0	1.5	1.4	1.9	0.3	0.5	2.5	4.5	0.1	2.2	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	3.3	78.6	11.3	1.1	1.6	1.3	2.7	2.7	0.2	0	0	0	0.1	0	323.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.6	5.1	0	0	0	0	0	0	0	0	4.9	0	0	0	0	15.9	0	0	0	0	0	0	0	0	0	Bipolar cells
KCNC1	Kv3.1	ENSG00000129159	Potassium voltage-gated channel subfamily C member 1	P48547	11	17734774-17856804	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	brain: 67.5	Cell type enriched	Detected in some	4	Bipolar cells: 36.6	Cancer enhanced	Detected in some		glioma: 1.1	Region enhanced	Detected in all		cerebellum: 67.5	Cell type enhanced	Detected in some		basophil: 5.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047634, HPA048249	Enhanced		Approved	Nucleoplasm,Nuclear membrane,Vesicles,Cytosol						Nucleoplasm, Nuclear membrane	Vesicles, Cytosol	HPA047634: AB_2680109, HPA048249: 	unprognostic (1.79e-2)	unprognostic (2.68e-1)	unprognostic (1.33e-1)	unprognostic (4.09e-3)	unprognostic (1.12e-1)	unprognostic (8.02e-2)	unprognostic (2.40e-1)	unprognostic (1.27e-1)	unprognostic (8.37e-2)	unprognostic (2.14e-1)	unprognostic (7.04e-5)	unprognostic (5.89e-2)	unprognostic (7.32e-4)	unprognostic (1.29e-1)	unprognostic (5.44e-2)	unprognostic (1.05e-2)	unprognostic (7.83e-2)	0.7	2.3	8.2	1	10	2.9	0.9	67.5	33.3	3	1	1	0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1	1.3	2.9	2	0	1.5	0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.1	1.2	0.5	0	0.1	0	0	0.1	0	0.2	1	0	0.2	0	0.9	1.1	1.8	0	0.3	0.3	2.1	0.6	3	0.2	0.4	0.5	0.2	0	0	0	0.1	0	0	0.8	0.5	1.4	0	0.5	0.5	1.2	1.5	0	0	0.8	7.5	0.9	0	0.4	7.1	4.4	0.4	0.5	0	0.4	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1	0.5	0.3	1	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2	0	0	0	0	0	36.6	1.7	0	0	0	0	0	0	0	0.5	7.4	0	0	0	0.2	0	0	0	0	0	0	1.6	7.5	0	0	8.4	0.3	0	0	1	0	1.5	0.2	0	0	0.1	7.4	0	0.4	5.4	4.5	0	0	0	0	0	Bipolar cells
AANAT	SNAT	ENSG00000129673	Aralkylamine N-acetyltransferase	Q16613	17	76453351-76470117	Enzymes, Predicted intracellular proteins	Biological rhythms, Melatonin biosynthesis	Acyltransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	retina: 27.7;testis: 8.2	Cell type enriched	Detected in some	9	Bipolar cells: 269.2	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.6;Daudi: 3.8;SCLC-21H: 5.7;U-266/70: 4.6;U-266/84: 4.8;U-698: 6.8	Not detected	Not detected							HPA054321			Supported	Cytosol	Intracellular and membrane					Cytosol		HPA054321: AB_2682449	unprognostic (7.89e-2)	unprognostic (2.62e-1)	unprognostic (1.41e-1)	unprognostic (2.44e-1)	unprognostic (1.83e-2)	unprognostic (2.03e-2)	unprognostic (1.05e-2)	unprognostic (3.09e-1)	unprognostic (1.01e-2)	unprognostic (3.61e-1)	unprognostic (9.30e-2)	unprognostic (4.19e-1)	unprognostic (2.81e-7)	unprognostic (1.04e-1)	unprognostic (6.00e-2)	unprognostic (4.47e-2)	unprognostic (1.34e-2)	0.3	0.2	1.2	3.8	0.8	2.7	0.3	1.3	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.4	1.8	0.3	1.2	1.5	0.3	0.3	0.3	3.3	1.7	0.7	0.4	0.3	0	0.9	0.3	1.9	0.3	0	27.7	0.3	0.3	1.8	3.3	0.7	0.3	1.2	2.2	0.2	8.2	0.3	0.3	0.8	0.3	0.3	0.9	0.3	1.3	1.3	2.2	0.1	1.8	0.2	0	0.9	4.6	0.7	0.5	0	0.1	0.5	0	0.4	0.3	0.1	0.1	3.3	3.8	0.5	0	0.7	1.2	0	0	0.3	0	1.2	0.1	0.7	0	0	0	0	0	0	0.1	0	0.2	1.2	0.4	0	2	0.4	0.6	0.1	0.1	1.2	1.5	0.4	0.2	0.2	2	0	0.1	5.7	0.4	0.1	0.2	1.6	0.6	2.8	0.7	0	0	1.8	0.2	0.1	4.6	4.8	6.8	1.2	0.4	0.8	2	0.1	2.2	0.2	0	0	0.6	0.1	0	0	1.3	0	0.2	0.6	1.8	0	1.3	0.1	0	1.2	0.8	1.3	0.9	1.2	1.5	1.7	0.7	1.9	0.3	0	0	0	0	0	269.2	0.3	0	0	0	0	11.8	0.1	0	0	5.4	0	0	0	0	0	0	0	0	0	0.1	6.4	1.2	0	0	12.3	0.3	0	0	0	0	6.6	0.2	0	0	0.3	29.7	0	0	1.7	1	0	0.1	0	0	0	Bipolar cells
KCNA5	HK2, HPCN1, Kv1.5	ENSG00000130037	Potassium voltage-gated channel subfamily A member 5	P22460	12	5043989-5046788	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Atrial fibrillation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 33.0	Cell type enriched	Detected in some	8	Bipolar cells: 153.4	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enriched	Detected in single	134	plasmacytoid DC: 13.3	Lineage enriched	Detected in single	134	dendritic cells: 13.3	Cell line enriched	Detected in single	12	NTERA-2: 10.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021516, CAB022562	Approved											CAB022562: , HPA021516: AB_2670732	unprognostic (3.87e-1)	unprognostic (9.91e-3)	unprognostic (1.94e-1)	unprognostic (3.23e-1)	unprognostic (2.64e-1)	unprognostic (7.06e-3)	unprognostic (1.20e-1)	unprognostic (4.61e-3)	unprognostic (1.34e-1)	unprognostic (2.14e-1)	unprognostic (2.37e-2)	unprognostic (5.08e-3)	unprognostic (6.73e-4)	unprognostic (1.92e-3)	unprognostic (1.90e-1)	unprognostic (2.86e-2)	unprognostic (3.08e-2)	3.4	1.4	1.9	0.9	8.6	0.7	1.2	0.4	2.3	1.6	3.3	7.2	0	1.1	1.7	2.6	7.6	2.1	2.3	33	3.5	5.8	1.9	0.8	2.3	0.9	2.3	2.2	3.2	2.4	0.6	7.5	3.4	8.8	3.7	1.3	7.2	0.9	2	5.3	0.6	1.1	3	3.9	1.2	3.3	0.8	4.9	0	1.1	3.4	1.2	4.5	3.4	0	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	0	0	0.2	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.3	0	0	1.9	8.6	0.4	2.3	3.5	5.8	2.3	2.2	8.8	4.9	0	0	0	0	0.8	153.4	8.6	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	3.4	0	0	0	0	0	0	0	0	1	0.1	0	0.4	0	3.4	12.9	19.1	0	0	0.3	0.1	0	0	0	Bipolar cells
TRPM1	CSNB1C, LTRPC1, MLSN1	ENSG00000134160	Transient receptor potential cation channel subfamily M member 1	Q7Z4N2	15	31001061-31161273	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Sensory transduction, Transport, Vision	Ion channel, Ligand-gated ion channel, Receptor	Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	retina: 99.0	Cell type enriched	Detected in some	5	Bipolar cells: 705.2	Cancer enriched	Detected in single	179	melanoma: 14.6	Low region specificity	Detected in single			Cell type enhanced	Detected in single		naive B-cell: 1.0	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	113	SK-MEL-30: 16.3	Not detected	Not detected			Not detected	Not detected			HPA014779, HPA071139	Enhanced		Uncertain	Golgi apparatus,Plasma membrane,Centriolar satellite						Centriolar satellite	Golgi apparatus, Plasma membrane	HPA014779: AB_2669090, HPA071139: 	unprognostic (5.28e-2)	unprognostic (1.35e-1)		unprognostic (9.89e-2)	unprognostic (3.07e-1)	unprognostic (1.97e-1)	unprognostic (1.70e-1)	unprognostic (1.29e-3)	unprognostic (2.83e-1)	unprognostic (2.89e-2)	unprognostic (1.67e-1)	unprognostic (1.45e-2)	unprognostic (2.58e-1)	unprognostic (7.84e-2)	unprognostic (6.20e-4)	unprognostic (1.48e-1)	unprognostic (2.63e-2)	0.1	0	0.4	0	0.6	0	0.1	0.1	0.3	0.4	0	0	0	0.2	0	0	0	0	0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0	0	0	0	0	0.1	0.3	0	0	99	0.4	0	0.2	10.4	0	0.1	1.9	0	0	2.9	0.1	0	0	0	0.1	0	0	1	0	0.3	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	16.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	1	0	0	0.3	0	0	0	0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0	0.3	0.1	0	0	0	0	3.8	705.2	0.4	0	0	0	0	0	0.2	0	0	30.8	0.1	0	0	0	0.1	0.3	0	0	0	0.1	12.7	0	0	0	2.4	0	0	150.1	0	0	10	0	0	0	0.6	18.1	0	0	7.9	3.8	0.9	0.8	0	0	0	Bipolar cells
RGS8	MGC119067, MGC119068, MGC119069	ENSG00000135824	Regulator of G protein signaling 8	P57771	1	182641816-182684576	Predicted intracellular proteins		GTPase activation, Signal transduction inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 29.8;thyroid gland: 15.0	Cell type enriched	Detected in some	5	Bipolar cells: 66.1	Group enriched	Detected in some	13	glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 6.7;Daudi: 2.4;SCLC-21H: 18.6;U-698: 3.8	Region enhanced	Detected in all		cerebellum: 477.3	Low region specificity	Detected in all			HPA076764	Enhanced											HPA076764: AB_2732321	unprognostic (6.75e-2)	unprognostic (2.62e-1)	unprognostic (1.03e-1)	unprognostic (9.29e-5)	unprognostic (2.60e-1)	unprognostic (2.37e-1)		unprognostic (9.29e-3)		unprognostic (1.16e-1)	unprognostic (3.78e-1)	unprognostic (2.40e-1)	unprognostic (3.23e-2)	unprognostic (7.08e-2)	unprognostic (2.98e-2)	unprognostic (6.37e-2)	unprognostic (1.02e-1)	0.3	2.6	2	0.4	23.3	0.3	0.3	3.7	7.5	0.3	0.3	2.7	0	0.5	0.3	0.4	0.5	0.3	0.5	0.3	1.4	3.3	0.4	0.4	0.4	0.6	3.9	2	1.2	0.3	0.3	0.5	0.3	29.8	0.3	0.4	1.3	0.6	0.3	0.3	0.3	0.3	0.6	2.6	0.3	0.4	5.7	7.1	0	15	0	0.9	0.3	0	0	0	0	0.1	0	0	0	0	0	6.7	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	18.6	0.6	0	0	0	0.1	0	0.3	0	0	0	0	0.1	0.3	0	3.8	0	0	0.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	23.3	3.7	3.5	1.4	3.3	3.9	2	29.8	7.1	0	0	0	0	0	66.1	1	0	0	0	0	0	0	0	0	11.2	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	14.7	0	0	0	0	0	0.5	0	0	0	0	3.7	0	0	0.2	0.2	0	0	0	0	0	Bipolar cells
KCNH5	eag2, H-EAG2, Kv10.2	ENSG00000140015	Potassium voltage-gated channel subfamily H member 5	Q8NCM2	14	62699454-63102037	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 4.6;brain: 9.2;retina: 5.7	Cell type enriched	Detected in some	15	Bipolar cells: 64.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HeLa: 10.1;RT4: 13.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA030487, HPA072351	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol						Centrosome	Nucleoplasm, Cytosol	HPA030487: AB_10609995, HPA072351: 		unprognostic (1.16e-1)		unprognostic (7.23e-2)	unprognostic (1.25e-1)	unprognostic (4.23e-2)		unprognostic (2.70e-1)	unprognostic (1.12e-1)	unprognostic (1.50e-1)	unprognostic (1.76e-2)	unprognostic (8.45e-2)		unprognostic (2.66e-1)	unprognostic (1.70e-3)		unprognostic (3.11e-1)	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0	0	0.3	0	0.3	0.5	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	2.2	0	0.2	0	0	0	0	0	0	0	1.1	0.8	1	0	0	0	0	0	10.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0.4	0	0	0	0	0	0	13.4	0.1	0	1.7	0	0	0.2	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	1.7	3.6	0.2	9.2	1.3	3	1.2	4.2	6.5	0	0	0	0	0.1	0	64.7	0.4	0	0	0	0	0	1.7	0	0	3.7	0	0	0	0	0.8	0.3	0	0	0	0.1	0	0	0	0	1.9	0	0	0	0	0	0.7	0	0	0	0	4.5	0	0	1.4	0.7	0	1	0	0	0	Bipolar cells
ARL5C	ARL12	ENSG00000141748	ADP ribosylation factor like GTPase 5C	A6NH57	17	39156894-39167484	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in some	7	lymphoid tissue: 21.1	Cell type enriched	Detected in single	4	Bipolar cells: 1.6	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	28	plasmacytoid DC: 2.7	Lineage enriched	Detected in single	28	dendritic cells: 2.7	Cell line enhanced	Detected in some		HMC-1: 1.4;JURKAT: 1.5;MOLT-4: 3.6;SuSa: 1.0	Low region specificity	Detected in many							HPA069849	Uncertain											HPA069849: AB_2686213	unprognostic (2.57e-1)				unprognostic (2.34e-1)								unprognostic (1.60e-7)	unprognostic (7.60e-2)	unprognostic (1.11e-2)			0.2	0.2	0.2	0.2	0.6	0	0.6	0.2	0.5	1.3	0.2	0	0	0	0	0.7	0.1	0.1	0	0.1	0.6	0.2	0.1	0.4	0.1	1.5	0.2	0	0.1	3	0	0.1	0.7	0.4	0.1	0.2	0.8	0.1	1.1	0.3	0.1	0.1	0	0.4	0.1	0.1	0.1	0	21.1	0.1	0	1.3	1.2	0.1	0	2.7	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	1.5	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.6	0	0	0.2	0.5	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0.2	0.6	0.2	0.5	0.6	0.2	0.2	0	0.4	0	0	0	0	0.1	0	1.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Bipolar cells
SLC4A10	NBCn2, NCBE	ENSG00000144290	Solute carrier family 4 member 10	Q6U841	2	161424332-161985282	Predicted membrane proteins, Transporters	Antiport, Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	blood: 31.2;brain: 48.1	Cell type enriched	Detected in some	12	Bipolar cells: 116.7	Cancer enhanced	Detected in single		glioma: 1.3	Low region specificity	Detected in all			Cell type enriched	Detected in some	8	MAIT T-cell: 31.2	Lineage enriched	Detected in single	78	T-cells: 31.2	Cell line enriched	Detected in some	11	Karpas-707: 14.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034755, HPA076725	Enhanced											HPA034755: AB_10670296, HPA076725: 	unprognostic (4.64e-4)	unprognostic (3.88e-1)	unprognostic (2.88e-2)	unprognostic (3.65e-2)	unprognostic (1.19e-2)	unprognostic (7.89e-3)	unprognostic (5.99e-4)	unprognostic (1.12e-1)	unprognostic (2.27e-1)	unprognostic (1.64e-1)	unprognostic (2.50e-2)	unprognostic (9.27e-2)	unprognostic (5.65e-2)	unprognostic (9.23e-3)	unprognostic (1.87e-1)	unprognostic (2.10e-3)	unprognostic (2.26e-1)	1	3.7	21.6	1.9	24.1	1.2	1.3	14.9	48.1	1.1	3.3	2.1	0	1.4	1	2.8	1	1.8	1.5	1	20.4	10.8	1	1.3	1.1	1.1	4.3	29.6	1	2.9	1	4.4	1	17.7	1.3	2.7	1.7	1	1.1	1	1	1.5	1.1	1.9	3	1.3	1.4	3.5	0	1	0	1.5	1.3	0.3	0	0	0	0	0.4	31.2	0.2	0	0	0	0	0	0	0	0	1.2	0	0.1	0	0.9	0.1	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	14	0.2	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.5	0	0.1	0	0	0	1.2	0	31.2	0	0.6	3.8	0	0	0	0	0	0.4	0	0	0	0.2	21.6	24.1	14.9	37.9	20.4	10.8	4.3	29.6	17.7	3.5	0	0	0	0	0	116.7	0.4	0	0	0	0	7.9	0	0	0	9.6	0	0	0	0	0	0	0	2.3	0.6	0	0	0	1.8	1.2	8.4	0	0	0	0	2.2	2.4	0.1	0	0	0	6.7	0	0	0.9	0.2	0	0	4.4	0	0	Bipolar cells
FAM171B	FLJ34104, KIAA1946	ENSG00000144369	Family with sequence similarity 171 member B	Q6P995	2	186693971-186765965	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 62.0	Cell type enriched	Detected in many	6	Bipolar cells: 137.0	Cancer enriched	Detected in many	5	glioma: 15.9	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Karpas-707: 25.4;U-138 MG: 17.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010639, HPA013434	Approved		Approved	Nucleoplasm,Mitochondria						Nucleoplasm, Mitochondria		HPA010639: AB_1852447, HPA013434: AB_2262499	unprognostic (2.52e-1)	unprognostic (7.75e-3)	unprognostic (1.27e-1)	unprognostic (1.04e-2)	unprognostic (4.03e-2)	unprognostic (9.43e-2)	unprognostic (6.78e-3)	unprognostic (2.68e-1)	unprognostic (1.88e-2)	unprognostic (1.52e-1)	unprognostic (4.24e-3)	unprognostic (1.47e-1)	prognostic unfavorable (9.51e-7)	unprognostic (4.63e-3)	unprognostic (1.52e-1)	unprognostic (2.24e-3)	prognostic unfavorable (5.03e-4)	3.1	13.1	32	2	32.6	1.1	3.7	12.7	62	6.7	2.1	5.8	0.1	1.6	7.1	2.6	2.4	3.2	4.9	1.9	25.5	13.1	1.8	1.1	2	1.6	9.1	23	9.7	1.6	11.4	13.4	3.5	9.7	3.2	2.5	1.4	17.8	2.8	1.3	3.8	1.9	4.5	8.4	2	2.4	1.6	10.4	0	2.7	0	1.7	2.9	1.8	0.3	1.3	1.1	1.7	2.4	1.1	0.5	2.3	2.8	4.2	13.1	12.5	9.5	0.1	2.6	4.6	3.2	4.6	7.7	12.6	0	0.9	7.3	5.5	0.3	5.7	2.5	4.6	0	3.3	2.8	1.3	0	1	0.8	1	12.1	1	2.5	2	4.2	7	2.2	0	25.4	6.1	1.6	1.6	0	5.6	0	2.8	0	8.1	0.6	5	9	13.2	7.2	1.3	0.8	3.5	2.6	1	0.6	4.1	17.6	2.3	0.3	1.6	6.8	6.5	0	5.4	0	2.4	1.1	0.7	0.3	0.8	1.7	0.7	0.3	1	0.9	0.6	0.2	0.6	1.1	0.4	2.4	1.6	1.3	0.1	0.5	32	32.6	12.7	30.4	25.5	13.1	9.1	23	9.7	10.4	0	0	0	2.1	7.9	137	0.8	10.2	0	2.3	0	13.7	7.9	0	0.7	1.4	10.5	0	0	0.3	0.8	6.6	1.2	0	0	1.7	22.3	4.6	8	0.3	2.5	7.2	1.1	3.3	1	0	16.5	0.5	0	13.1	0.1	15.5	0	4.1	0.1	1.4	4.5	6.9	0	0	0.5	Bipolar cells
NYAP2	KIAA1486	ENSG00000144460	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2	Q9P242	2	225399710-225654018	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	brain: 17.9;pituitary gland: 13.5	Cell type enriched	Detected in some	6	Bipolar cells: 17.8	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 2.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045531, HPA056945	Uncertain		Approved	Mitochondria,Cytosol						Mitochondria	Cytosol	HPA045531: AB_10960749, HPA056945: 	unprognostic (2.49e-1)	unprognostic (3.34e-1)		unprognostic (1.24e-1)	unprognostic (2.63e-1)	unprognostic (2.35e-1)		unprognostic (6.13e-3)		unprognostic (3.33e-1)	unprognostic (2.08e-1)		unprognostic (1.32e-8)	unprognostic (9.83e-2)	unprognostic (2.92e-1)	unprognostic (6.46e-2)	unprognostic (1.27e-1)	0.8	1.1	10.8	1	16.4	1.4	0.7	17.9	11.9	0.6	0.7	0.8	0	1	0.7	0.7	1.2	0.6	0.8	0.7	8.5	2.5	0.7	0.7	1.9	1.1	2.6	8.5	0.6	0.8	0.6	13.5	0.7	2.5	0.7	0.8	0	0.7	0.6	2.6	1.2	0.9	0.6	2.7	0.9	0.8	1	2.9	0	0.6	0	0.8	1.2	0.6	0.5	0.5	2.1	0.3	0.2	0.4	0.1	0	0.6	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0	0	0.4	0	0	1.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.8	0	0	0	0.1	0	0.7	1	2	6.2	0	0	0.1	0	0	0	0.1	2.4	0.1	0	0.1	0	0.1	0.1	0	0	2.1	0.3	0.2	0.3	0.2	0.4	0.3	0.2	0.1	0	0.5	0.3	0.4	1.2	0.2	0.2	0.5	0.1	0.1	10.8	16.4	17.9	11.9	8.5	2.5	2.6	8.5	2.5	2.9	0	2.9	0	1.1	1.1	17.8	0.3	0	0	1.2	0	2	0.2	0	0.4	0.4	0	0	0	1	0.1	0.4	0.8	0	0	0.1	0	0	0	0	0.2	0	0.8	0	0	0	0.1	1.8	0	0	0	1.7	0	1	0	0.2	0.9	0.1	0	0	0.8	Bipolar cells
LRTM1	HT017	ENSG00000144771	Leucine rich repeats and transmembrane domains 1	Q9HBL6	3	54918237-54967088	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3	Cell type enriched	Detected in many	14	Bipolar cells: 403.4	Cancer enhanced	Detected in single		urothelial cancer: 0.5	Region enriched	Detected in single	7	pons and medulla: 2.9	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 4.3	Not detected	Not detected			Low region specificity	Detected in many																				unprognostic (2.28e-1)	unprognostic (1.58e-2)								unprognostic (9.56e-2)	unprognostic (2.16e-1)		unprognostic (1.87e-3)	0.3	0.1	0.3	0	0.3	0	0.3	0.1	0.2	0.1	0.2	0	0	0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0	0.3	0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0	18.8	2.1	0.4	22.5	0.1	0.3	0	1	12.2	0.1	0.3	0	0	0.1	15.3	0.5	0.1	0.1	0.7	1	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0	1.8	0	0.5	0.9	1.6	0.3	1.3	0	0.8	0.8	0	1	0.4	1.5	0.6	1	0.2	4.3	1.1	0.9	0.2	0.5	1.1	1.8	0.4	0.7	0.2	0.1	0.1	0.3	0.1	1.6	0.3	0.2	0.4	2.3	1.5	0	0.5	0.1	0.3	1.3	0.2	0.7	0.5	0.7	0.5	2.3	0.3	0.7	1.2	0.3	0	0.7	0.9	0.7	0.1	0	1	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0	2.9	0	0	0	0	0.7	0.3	403.4	0.4	0	0	0	1.8	15.7	7.8	0	0	2	0.2	0	0	0.3	1.1	0.8	0.4	0	0	0.5	1.6	0	0	0	0	5.5	0	0	0	0	16.2	1.4	0	4.2	0	28.5	0	1	3	2.2	0.4	18.5	0	0	0.4	Bipolar cells
HMGCLL1	bA418P12.1, DKFZP434G1411	ENSG00000146151	3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1	Q8TB92	6	55434369-55579214	Enzymes, Predicted intracellular proteins		Lyase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 18.4;pituitary gland: 14.8	Cell type enriched	Detected in some	4	Bipolar cells: 14.1	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SCLC-21H: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.74e-3)		unprognostic (1.54e-2)	unprognostic (4.08e-3)	unprognostic (6.11e-2)	unprognostic (1.41e-1)	unprognostic (9.54e-3)	unprognostic (8.97e-3)		unprognostic (2.12e-2)	unprognostic (9.27e-3)	unprognostic (4.11e-2)	unprognostic (1.18e-4)	unprognostic (3.13e-3)	unprognostic (7.57e-2)	unprognostic (2.55e-1)	unprognostic (1.52e-1)	2.2	7.7	7.7	0.9	14.5	0.5	3.4	10.1	18.4	2.2	1.7	3.1	0.3	0.8	0.8	0.6	2.5	1.5	1.8	4.1	8.7	12.6	2.2	1.8	5.7	1.1	9.1	10	1.3	3.6	0.8	14.8	12.5	14.6	7	2.2	4.8	2.1	2.9	2.4	0.6	2.4	1.6	10.1	0.6	2.9	5.5	3.3	0	0.9	0	1	2.7	1.1	0	0	0	0	0	0	0	0	0.7	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.3	0	0.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.7	0	0	1.2	0	0	0	0	0	0	0	11.7	0.3	0	0	0	2.3	0.9	0	0	0	0.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	14.5	10.1	12.6	8.7	12.6	9.1	10	14.6	3.3	0	2.2	0	0	0	14.1	0.4	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	1.3	0	0	0	0.1	0	0	3.1	0	0.4	0.3	0	0	0	0	1.5	0.5	0	0	0	1.4	0	3.4	0.7	0	0	0	0	0	0	Bipolar cells
GABRR1		ENSG00000146276	Gamma-aminobutyric acid type A receptor rho1 subunit	P24046	6	89177501-89231278	FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		retina: 12.3;testis: 4.6	Cell type enriched	Detected in some	11	Bipolar cells: 53.4	Not detected	Not detected			Region enriched	Detected in single	6	amygdala: 2.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6	Not detected	Not detected																				unprognostic (5.75e-2)	unprognostic (3.92e-2)	unprognostic (1.12e-1)	unprognostic (2.90e-2)	unprognostic (5.78e-2)	unprognostic (4.90e-2)		unprognostic (8.32e-3)	unprognostic (2.52e-3)	unprognostic (1.74e-1)	unprognostic (1.82e-1)	unprognostic (1.43e-1)	unprognostic (1.62e-5)	unprognostic (1.18e-1)	unprognostic (9.90e-2)	unprognostic (2.12e-2)	unprognostic (2.29e-1)	0.4	0	2.2	0.1	0.1	0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.2	1	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0	0.1	0.2	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	3.3	6.7	0	0	0.2	0	0	0.1	0.1	0	0	0	0	4.6	0	1	0	0.1	0.2	0	0	0.1	0.2	0	0	0	0	0	0.1	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.2	0.1	0	0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0	0	0	0	0.2	53.4	0.3	0	0	0	0	3.9	0.3	0	0	2.1	0	0	0	0	0	0	0	0	0	0	4.8	0	0	0	0.4	0	0	0	0	0	0.5	0	0	0.4	0	3.8	0	0.3	0	0.2	0	0.2	0	0	0.1	Bipolar cells
PRDM8	KMT8D	ENSG00000152784	PR/SET domain 8	Q9NQV8	4	80183879-80204329	Disease related genes, Predicted intracellular proteins, Transcription factors	Neurogenesis, Transcription, Transcription regulation	DNA-binding, Methyltransferase, Transferase	Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 31.0;prostate: 30.9;seminal vesicle: 34.0	Cell type enriched	Detected in many	31	Bipolar cells: 289.0	Cancer enhanced	Detected in many		prostate cancer: 4.6	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1	Region enhanced	Detected in many		hippocampal formation: 31.4	Group enriched	Detected in all	4	amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7	HPA057253			Approved	Nuclear bodies		No				Nuclear bodies		HPA057253: AB_2683382	unprognostic (2.33e-2)	unprognostic (1.08e-1)	unprognostic (1.23e-1)	unprognostic (2.67e-1)	unprognostic (1.15e-1)	unprognostic (1.68e-1)	unprognostic (1.65e-1)	unprognostic (7.95e-2)	unprognostic (1.19e-1)	unprognostic (1.76e-1)	unprognostic (2.34e-1)	unprognostic (2.80e-2)	unprognostic (1.89e-11)	unprognostic (4.64e-2)	unprognostic (1.69e-1)	unprognostic (1.39e-1)	unprognostic (2.56e-1)	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31	9.3	8.2	10.9	1.8	2.1	8.2	3	2.8	3.7	2.7	1.9	30.9	6	1.4	0.9	2	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34	3	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9	0	1.1	0	3.5	9	8.2	2.2	0.5	2.1	0	0.7	2.4	0.4	0.9	0	0.3	0	0.9	3.3	0	2.5	9	1.2	1.4	0	0.9	0	0	3.1	0.8	0.3	0	1	5.4	3.7	0.8	0.3	0	0	1.9	3.7	1.1	2	0	4.9	1.4	12.2	0.1	1	0	1.6	18.2	0	1.7	20.4	0	0	7.4	0.6	0	0	0.5	0.1	44.1	6.1	0.1	0	0	0	0	1.9	3.8	3.2	0.4	2.3	0.1	0.7	0	0	7.9	1.8	0.4	0	0	0	1.6	0	2.4	0.3	2.1	2	0.3	2.2	1.3	0.7	2.1	0.7	0	0.5	0.9	0.4	17.6	10.1	3.6	31	30.9	6	12.3	18.1	7.5	9	0	0.3	3.5	3.2	0.6	289	1.8	0	6.7	9.1	1.8	2	0	0	0	1.4	1	0	0	0.2	0.1	3	2.3	0	0	0.5	3.2	0	0	0	3.3	2.8	0.7	1.7	1	0	4.1	0.4	0	3.2	0	9.2	0	1.7	0.4	0.5	0.1	0.1	1	0	0.6	Bipolar cells
KCNMA1	KCa1.1, mSLO1, SLO	ENSG00000156113	Potassium calcium-activated channel subfamily M alpha 1	Q12791	10	76869601-77638369	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	7	Bipolar cells: 372.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	5	intermediate monocyte: 5.5;memory B-cell: 1.7;non-classical monocyte: 3.7	Group enriched	Detected in many	5	B-cells: 1.7;monocytes: 5.5	Cell line enhanced	Detected in many		BJ: 27.4;hTERT-HME1: 32.2;PC-3: 43.8;U-138 MG: 31.6;U-87 MG: 30.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054648	Approved											HPA054648: AB_2682556	unprognostic (1.25e-1)	unprognostic (2.23e-2)	unprognostic (1.86e-2)	unprognostic (5.29e-2)	unprognostic (9.43e-2)	unprognostic (2.25e-1)	unprognostic (1.77e-1)	unprognostic (2.81e-2)	unprognostic (1.87e-1)	unprognostic (1.34e-1)	unprognostic (4.12e-3)	unprognostic (1.20e-1)	unprognostic (2.26e-2)	unprognostic (1.42e-2)	unprognostic (5.19e-2)	unprognostic (1.42e-2)	unprognostic (3.99e-3)	6	8.1	12.5	8.8	13.6	1.1	7.1	8.2	18.5	36.3	39	5.7	27.9	4.8	54	19.7	20.7	18.3	15.6	2.7	10.8	8.2	2	6.6	4	6.2	7.4	16.5	7	4.1	0.7	10.1	3.3	10.1	30.1	13.2	6.6	24	47.6	37.1	1.8	8.6	55.1	6.8	10.4	14.8	2.6	4.9	0.4	1.4	2.7	2.5	21.7	12.6	1.7	0.6	0.3	5.5	0	0	0.3	0	8.2	0	0.1	1.3	7.1	0.1	27.4	24.5	6.6	3.3	1.8	0.1	0	0.2	20.4	15.8	0	0	16	4.1	16.2	0.1	0	0	0	12.8	0	0.1	4.9	2.9	10.6	32.2	23.5	2.6	0.1	0	0	11.6	0.3	0.5	0	0.5	0	43.8	0	1	0	4.2	0	2.5	0.3	0	0.7	0	3.4	3.3	0	17.7	31.6	3.5	5.6	24.2	0	0	0	30.8	0	12.3	0	0.2	0	0	5.5	0	1.7	0	0	0.6	0.3	0	0	0.3	0	3.7	0	0	0.3	12.5	13.6	8.2	18.5	10.8	8.2	7.4	16.5	10.1	4.9	0	7	2.7	41.2	1.8	372.4	2.5	2.5	0	6.8	1.8	56.9	0.3	24.9	2.9	55.5	0.9	1.5	0	9.7	0.1	4.1	44.9	0	23.7	11.3	6.4	4.7	2.5	53.8	46.9	3.4	19.8	45.5	4.6	52.9	48	11.6	0.8	1.1	0.8	15.2	6.5	17.9	1.4	1.6	0.3	0.2	0.7	1.1	1.4	Bipolar cells
CELF5	BRUNOL5	ENSG00000161082	CUGBP Elav-like family member 5	Q8N6W0	19	3224703-3297076	Predicted intracellular proteins	mRNA processing	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 35.8	Cell type enriched	Detected in some	6	Bipolar cells: 91.5	Cancer enhanced	Detected in some		glioma: 2.6	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 6.1;REH: 7.5;SCLC-21H: 7.8;SH-SY5Y: 4.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA042012, HPA060336	Enhanced	Supported										HPA042012: AB_10796896, HPA060336: AB_2684256	unprognostic (1.09e-1)	unprognostic (9.24e-2)	unprognostic (9.25e-3)	unprognostic (3.48e-2)	unprognostic (1.69e-1)	unprognostic (5.44e-2)	unprognostic (2.06e-1)	unprognostic (1.17e-1)	unprognostic (1.22e-3)	unprognostic (1.35e-1)	unprognostic (4.70e-3)	unprognostic (1.11e-2)	unprognostic (1.74e-3)	unprognostic (1.23e-2)	unprognostic (2.63e-2)	unprognostic (1.25e-1)	unprognostic (8.07e-2)	0.8	1.1	16.2	0.8	21.2	0.7	1.5	19.6	35.8	0.8	1	0.8	0	0.8	1.3	1.1	0.8	1.5	0.7	0.8	9.5	12.2	0.8	0.8	0.8	0.7	2.6	15.5	7.1	1.1	2.6	0.5	0.8	3.4	0.9	1	0	2	1	1.3	0.8	0.9	0.8	0.9	0.8	1.2	2.5	2.7	0.2	0.8	0	0.7	0.7	0	0.1	0	0.1	0.2	0	0.2	0	0	0.4	1.3	1.7	0	0	1.3	0	0.1	0.1	0	0	0.3	0	1	0	0.4	0.1	0.2	0	0	0.4	0.3	0	0	0.1	0	0	0.1	0	0	0	0	0	0	1.3	2.1	0.1	0	1	0.1	0	6.1	2.4	0.1	7.5	0	0	0	0	7.8	4.7	0.3	0.5	0	0.3	0.8	0	0	0	0.2	0.1	0	0	0	0	0.2	0	0	0	0.2	0.1	0.2	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	16.2	21.2	19.6	19.6	9.5	12.2	2.6	15.5	3.4	2.7	0	0	0	1.7	0.3	91.5	1.7	5.1	0	0	0	0	0.3	0	0.5	15	0	0.2	0	0.2	0.1	0.2	1.6	0	0.4	0.1	7.9	1.2	0	0	10.5	0.3	0	0	0	0.9	2	0.7	0	2.1	0	3.5	0	0.5	1.1	8.3	0.3	0	0	1.2	0.8	Bipolar cells
PLXDC1	TEM3, TEM7	ENSG00000161381	Plexin domain containing 1	Q8IUK5	17	39063303-39154394	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Bipolar cells: 313.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BJ hTERT+: 13.2;MOLT-4: 4.1;U-87 MG: 8.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012805	Approved				Intracellular and membrane				6000000			HPA012805: AB_1857893	unprognostic (4.28e-1)	unprognostic (3.55e-1)	unprognostic (2.56e-2)	unprognostic (2.15e-1)	unprognostic (9.50e-2)	unprognostic (1.13e-2)	unprognostic (2.35e-2)	unprognostic (2.23e-2)	unprognostic (4.07e-3)	unprognostic (6.07e-3)	unprognostic (4.62e-3)	unprognostic (8.69e-2)	prognostic unfavorable (9.15e-8)	unprognostic (9.37e-3)	unprognostic (1.72e-2)	unprognostic (2.42e-1)	unprognostic (2.33e-2)	6.1	3.5	6.6	5.7	13.8	1.4	10	13.3	13.8	6.9	5.1	5	5.9	2.4	15.1	7.8	14.6	10.4	17.1	18.4	7.6	6.3	3.7	1	5	6	7.8	6.3	18.2	4.3	1.3	3.1	2.7	7.5	5.2	3.7	19.7	4	6.6	8.4	5.1	5	13.2	3.7	2.3	4.5	6	4.8	27.8	3.4	10.5	10.8	5.9	5.2	0.3	2	1	0.3	2.2	4.9	1.6	0.1	0	0.2	2.1	0.4	0	0.3	0.2	13.2	1	0.6	0.2	3.1	0.2	0.3	0.4	0.1	0.3	0.3	0.2	0.7	0.1	1.1	0.4	1	0.1	0.3	0.5	0.1	0.5	0.2	0.5	0.1	0.2	0	1.3	0.1	0.9	0.1	1.5	4.1	0.4	0.5	0.1	0	0.5	0.7	0.5	0	0.1	2.1	0.2	0.1	0.3	0	0.3	0.3	0.3	0	1.6	0.9	0.6	0.3	0.2	0.1	0.2	8.6	0.6	0.2	0.5	0.3	0.2	3.8	0.1	3.3	0.2	1.3	1.4	0	0.3	4.9	4.9	1	2.2	0.1	2	0.1	1.6	6.6	13.8	13.3	13.8	7.6	6.3	7.8	6.3	7.5	4.8	0	12.2	0	0.8	4.6	313.9	3.2	0	2.7	3.4	0	19.6	0.1	0	0	1.8	3.4	0	0	0.2	0.1	12.1	0.8	1.1	0	0.1	6.4	0	0.6	1	5.5	0.6	3.5	6.8	8.2	0	12	0.1	0	1.1	0	23	45.3	22.1	0.5	0.6	3.9	0	4.3	0	0.4	Bipolar cells
EDIL3	DEL1	ENSG00000164176	EGF like repeats and discoidin domains 3	O43854	5	83940554-84384793	Predicted secreted proteins	Cell adhesion	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 85.3	Cell type enriched	Detected in many	6	Bipolar cells: 147.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		hTERT-RPE1: 105.9;LHCN-M2: 32.2;TIME: 38.1;U-2 OS: 32.4;U-87 MG: 21.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA020415	Approved				Secreted to blood							HPA020415: AB_2670434	unprognostic (9.93e-3)	unprognostic (2.38e-1)	unprognostic (2.71e-2)	unprognostic (8.63e-2)	unprognostic (2.22e-1)	unprognostic (1.01e-1)	unprognostic (1.16e-2)	unprognostic (9.19e-2)	unprognostic (6.64e-3)	unprognostic (2.98e-1)	unprognostic (1.56e-1)	unprognostic (1.04e-1)	unprognostic (1.03e-3)	unprognostic (2.52e-2)	unprognostic (1.05e-1)	unprognostic (1.52e-2)	unprognostic (1.28e-3)	7.9	12.6	29.3	7.2	45.3	0.2	3.6	5.5	46.2	10.9	20.1	77	0.3	9.3	15.6	26.2	9.9	4.9	19.2	10.8	42.6	24.7	6.5	1.1	11.7	0.5	67.3	22.5	6.1	2	0.9	2.1	2.6	37.1	8.1	21.8	5	2.5	13.5	1.2	5.5	14.3	14.4	85.3	1.8	10.6	1.4	61.6	0	2.4	0.1	2.1	7.7	5.1	0	0	0	0.7	0	0	0	0	0.2	0.2	0	0.7	0	0	0.9	0	2.4	3.2	0	4	0	0	0	1.7	3.7	0	0.1	1.8	0	1.7	0	11.5	0	19.7	0.1	0	5	0.5	11.7	1.6	105.9	4.1	0	0	0	32.2	0	0	0	1.6	0	7.5	0	7.9	0	5.4	0	0.8	0.1	0	0	0	5.2	0	0	38.1	11.8	32.4	0.4	10.5	0.3	0	0	21.8	0	3	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	29.3	45.3	5.5	30.1	42.6	24.7	67.3	22.5	37.1	61.6	8.9	5.9	0	1.5	10.8	147.4	10	0	1.4	2.3	3.5	2	0.2	0	0.1	25.1	3.5	0	0	0	0	17.5	0.7	5.7	0	0.2	4.8	22	2.5	0	12.5	2.3	0	3.3	0	8.3	4.1	0.7	5.8	3.5	0.7	9.6	6.5	24.5	1.1	0.6	14.1	0.3	0	9.7	0.4	Bipolar cells
NETO1	BCTL1, BTCL1	ENSG00000166342	Neuropilin and tolloid like 1	Q8TDF5	18	72742314-72868146	Predicted intracellular proteins, Predicted membrane proteins, Transporters		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	brain: 47.9	Cell type enriched	Detected in some	38	Bipolar cells: 163.9	Cancer enhanced	Detected in some		glioma: 1.2	Low region specificity	Detected in many			Group enriched	Detected in some	27	memory B-cell: 1.6;naive B-cell: 3.7	Lineage enriched	Detected in single	38	B-cells: 3.7	Cell line enhanced	Detected in some		MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA064630			Approved	Golgi apparatus	Intracellular and membrane					Golgi apparatus		HPA064630: AB_2685305	unprognostic (4.02e-2)	unprognostic (4.08e-3)	unprognostic (2.75e-1)	unprognostic (1.55e-2)	unprognostic (6.04e-2)	unprognostic (1.35e-5)	unprognostic (4.05e-1)	unprognostic (4.73e-2)	unprognostic (3.09e-1)	unprognostic (1.56e-1)	unprognostic (6.63e-2)	unprognostic (1.20e-1)	unprognostic (1.73e-2)	unprognostic (3.70e-2)	unprognostic (3.35e-2)	unprognostic (1.59e-1)	unprognostic (9.13e-3)	2	0.8	9.1	1.3	18.3	1	1.7	0.4	47.9	0.9	0.9	0.7	0	0.8	0.9	0.9	1	0.8	0.9	1.4	15.9	3.9	1	0.8	0.9	3.8	3	15.1	0.8	0.8	1	0.3	0.8	5	0.9	1.1	3.9	1.1	0.8	0.8	1.2	0.8	0.8	1.1	4	0.9	2	2.8	0.8	2.3	0	2.7	1.2	0.2	3.7	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	0	0	0	0	0	15.1	0	6.9	0	0	14.9	0	23.7	3.7	15.7	20.9	0	0	0.1	0	0.2	0	0	0	0	7.7	0	0	0	0	0	0.2	0	1	0	0	0	0	0	0	1.6	0	0	0	3.7	0	0	0	0	0	0	0	0	9.1	18.3	0.4	22.8	15.9	3.9	3	15.1	5	2.8	0	0	0	0	0	163.9	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	4.3	0	0	0	0.2	0	0	0	0	0	Bipolar cells
TMEM130	DKFZp761L1417, FLJ42643	ENSG00000166448	Transmembrane protein 130	Q8N3G9	7	98846488-98870771	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4	Cell type enriched	Detected in some	8	Bipolar cells: 49.7	Cancer enhanced	Detected in many		renal cancer: 9.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 4.8	Lineage enriched	Detected in many	5	granulocytes: 4.8	Cell line enhanced	Detected in some		BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012928	Uncertain		Supported	Golgi apparatus						Golgi apparatus		HPA012928: AB_1858085	unprognostic (1.36e-2)	unprognostic (1.33e-3)	unprognostic (3.85e-2)	unprognostic (1.56e-2)	unprognostic (3.61e-3)	unprognostic (3.23e-2)	unprognostic (2.97e-1)	prognostic favorable (7.84e-4)	unprognostic (1.07e-2)	unprognostic (1.17e-2)	unprognostic (4.69e-2)	unprognostic (5.65e-2)	unprognostic (1.86e-3)	unprognostic (7.90e-3)	unprognostic (1.22e-1)	unprognostic (1.17e-2)	unprognostic (1.73e-1)	1.3	28.2	27.3	2	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0	1.6	1.8	8	2.2	1.7	2.2	1.4	29.3	47	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24	1.3	25.8	2.7	1.9	1	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0	1.2	1.7	1.2	1	0.6	4.8	0.9	1	0.7	0.3	0	0.6	0	0	0.2	0	0.2	3.4	7.6	0.6	0.5	0.1	0.1	0.1	7.4	1.9	8	0.1	0	0	0.1	0.2	0.4	0.1	0.2	0.1	0	0	0.5	0.1	0	0	0	12.8	0.3	0.1	0.1	0.6	0.4	0.6	0.1	0.1	4.4	0	0	0.1	0	0.7	0.1	0	0.5	9.1	0.1	0.1	0	3	0	0	0	0.1	0.6	0	0.2	0.4	0.2	0.1	0.3	0.4	0.1	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1	0.7	0.6	4.8	1	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47	13.4	35.1	25.8	3.9	0	0	0	0.3	0.3	49.7	0.8	2.5	0	3.4	1.8	2	0.1	0	0	1.3	0.3	0	0	0.2	0.1	1.1	0.3	0	0	0.1	0	0	0.6	0	1.9	0.9	0.2	0	0	0	1.3	0	0	6.3	0	3.7	0	0.3	0.4	0.7	0.3	0.2	0	0	0.1	Bipolar cells
ELFN2	dJ63G5.3, KIAA1904, LRRC62, PPP1R29	ENSG00000166897	Extracellular leucine rich repeat and fibronectin type III domain containing 2	Q5R3F8	22	37367960-37427470	Predicted membrane proteins		Protein phosphatase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 30.0	Cell type enriched	Detected in some	11	Bipolar cells: 43.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA000781	Approved		Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA000781: AB_1079280	unprognostic (2.74e-1)	unprognostic (6.81e-2)	unprognostic (2.80e-2)	unprognostic (1.31e-5)	unprognostic (3.28e-1)	unprognostic (2.51e-2)	unprognostic (7.76e-2)	unprognostic (4.25e-2)	unprognostic (6.05e-2)	unprognostic (2.80e-2)	unprognostic (2.02e-1)	unprognostic (4.51e-1)	prognostic unfavorable (7.21e-4)	unprognostic (1.29e-1)	unprognostic (1.95e-1)	unprognostic (1.77e-1)	unprognostic (1.95e-1)	1	2.1	26.8	0.9	10.9	0.9	0.9	0.7	30	0.9	0.9	1.9	0	0.9	0.9	0.9	0.9	1	1.9	0.8	16.2	8.7	1.2	0.8	2	1	6.7	15	0.8	1.1	0.8	0.1	0.8	5.8	2.2	0.9	0.9	0.9	0.9	0.9	1.5	0.9	0.8	3.8	0.9	1.1	4.2	3.9	0.1	0.8	0	0.9	0.9	0.1	0.4	0	0	0	0	0	0	8.7	3.7	0	0	0	0.7	0	4	2.1	0.9	0	1.4	8.4	0.2	5.2	2.8	9.4	6.1	0.4	0.8	0.1	0.2	0	0	3.9	0	0.2	0	0.1	0.7	0.1	0.3	1.2	3.5	0.3	0.1	0	0	0.3	0.4	0	0	0.2	5.2	8	0.1	0	8.4	16.4	0	0.7	0	3.6	4.6	0	0	0	0.1	0.4	0	18.7	0.1	2.5	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	26.8	10.9	0.7	16.8	16.2	8.7	6.7	15	5.8	3.9	0	3.2	0	0	0.1	43.2	0	2.5	0	0	0	3.9	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	3.2	0	0	0	0.6	0	0	0	0	0	0.8	0.1	0	0	0.3	1.6	0	0	2.1	0.4	0	0	0	0	0	Bipolar cells
RCOR2		ENSG00000167771	REST corepressor 2	Q8IZ40	11	63911221-63916844	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 16.6	Cell type enriched	Detected in some	4	Bipolar cells: 15.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes				Nucleoplasm	Vesicles, Midbody	HPA021638: AB_10960885	unprognostic (1.96e-2)	unprognostic (1.15e-1)	unprognostic (4.10e-2)	unprognostic (1.98e-3)	unprognostic (3.10e-2)	unprognostic (5.86e-2)	unprognostic (2.33e-4)	unprognostic (8.64e-2)	unprognostic (1.46e-1)	unprognostic (4.80e-2)	unprognostic (1.67e-1)	unprognostic (1.72e-3)	unprognostic (2.62e-1)	unprognostic (1.75e-1)	unprognostic (3.51e-1)	unprognostic (9.93e-2)	unprognostic (6.06e-3)	0.8	1.4	3.3	0.7	8	0.3	0.7	9.3	16.6	3	1.4	3.4	0	2	3.5	2.6	1.2	3.7	1.6	5.9	4	2.6	0.7	0.4	1	0.3	2.4	3.8	5.2	1.4	3.2	5	1.8	1.8	1.7	1.7	3.3	2.3	1.7	3.1	0.6	1.6	2.5	2.2	0.5	1.2	7	2.5	4.1	0.6	0.6	0.3	2.5	0.8	0.2	0	0	0	0	0	0	0	0.5	18.1	1.2	0.3	1.5	5.4	0.1	0.3	0.2	0.6	0.7	0.1	0.1	0.2	0.4	0.3	0.2	7.9	0	0.2	0.2	1	0.2	0.1	5.8	3	0	0.1	1.8	0	0.3	0	0	0.1	2.4	0.9	0	0	1.6	1.6	6.4	23.4	2.3	0	5.8	1	0.5	0	0	36.7	24.4	0.1	1.6	0.9	4.6	1.3	2.2	0.1	0	1.2	0	0	0.1	0	0.2	0	0.1	0.8	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	3.3	8	9.3	11	4	2.6	2.4	3.8	1.8	2.5	0	0	0	0	0	15.7	1.7	0	0	0	0	0	0.4	0	0	0	0	0.4	0	0.2	3.7	0.5	0	0	0	0.2	3.2	1.2	0	0	0	1.4	0	0	0	1.1	0.9	0.3	0	0.4	0	2.1	0	0.2	0.7	2.6	0.3	0.7	0	1.1	0	Bipolar cells
CABP2	DFNB93	ENSG00000167791	Calcium binding protein 2	Q9NPB3	11	67518912-67524517	Disease related genes, Predicted intracellular proteins	Hearing, Sensory transduction, Vision		Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	8	retina: 10.7	Cell type enriched	Detected in some	8	Bipolar cells: 54.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		AF22: 1.9	Region enriched	Detected in single	22	cerebellum: 5.2	Not detected	Not detected																																	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	10.7	0	0	0	0	0.1	0	0	0	0	1.3	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54.5	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	6.5	0	0	0	0.1	0	0	0	0	0	Bipolar cells
KCNG4	Kv6.4	ENSG00000168418	Potassium voltage-gated channel modifier subfamily G member 4	Q8TDN1	16	84218667-84239750	Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		retina: 8.8	Cell type enriched	Detected in some	18	Bipolar cells: 29.7	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AN3-CA: 3.2	Region enhanced	Detected in many		cerebellum: 101.5	Low region specificity	Detected in many																				unprognostic (3.54e-1)									unprognostic (6.67e-2)				0.7	2.8	2.6	0.2	1.8	1.8	0.1	0.7	3.5	0	0.1	1.6	0	0.1	0.3	0.8	0.4	0.2	0.3	0.1	2.8	2	0.2	0.1	0.1	0.5	2.8	0	0.6	0.3	0	1.1	0.2	2.3	0.4	0.2	8.8	0.4	0.1	1	2.1	0.4	0.1	1.3	0.4	0.4	0.7	1	0	0.4	0	0.1	0.4	0	0.9	0.8	2.4	0.6	1.3	0.6	0.2	0.3	0.3	0.9	3.2	0.3	0.3	0.9	0.6	0	0	0	0.6	0.7	0.5	0.4	0.2	0.1	0.4	0	0	0.2	0.2	0.7	0.5	1.1	1	0.2	0.1	0.3	0.1	0	0.1	0.3	0.6	0.1	0.5	0.6	1.4	0	0.8	0.3	1	0.8	0	0.8	0.4	0.9	0.1	0	0.8	0.8	0.7	0.7	0.4	1.8	0.3	0.6	0.3	0.5	0.5	0.4	0.9	0.4	0.6	0.3	0.4	0.7	0.5	0.6	2.4	0.6	0.6	0.4	0.3	0.3	0.4	0.4	0.3	0.2	0.9	0.4	0.6	2.1	1.3	0.3	0.8	0.4	0.2	2.6	1.8	0.7	3.5	2.8	2	2.8	0	2.3	1	0	0	0	0	0	29.7	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	Bipolar cells
ZNF804A	C2orf10	ENSG00000170396	Zinc finger protein 804A	Q7Z570	2	184598366-184939492	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	4	brain: 31.6;lymphoid tissue: 9.6	Cell type enriched	Detected in some	5	Bipolar cells: 31.9	Cancer enhanced	Detected in single		glioma: 0.9	Region enriched	Detected in many	4	cerebellum: 31.6	Cell type enhanced	Detected in some		memory B-cell: 2.0	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029195	Uncertain		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA029195: AB_10603011	unprognostic (1.10e-1)	unprognostic (1.00e-1)	unprognostic (1.06e-2)	unprognostic (2.05e-2)	unprognostic (1.08e-2)	unprognostic (1.26e-2)	unprognostic (1.50e-1)	unprognostic (2.41e-1)	unprognostic (4.45e-1)	unprognostic (2.38e-2)	unprognostic (2.83e-2)	unprognostic (5.20e-2)	unprognostic (4.98e-4)	unprognostic (6.21e-2)	unprognostic (4.04e-1)	unprognostic (8.45e-2)	unprognostic (4.93e-2)	0.4	1	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0	4.4	0	2.9	1.8	2.1	2	1.2	1	1.7	0	0	0.3	0	0	1.2	0	0	0	0	2.1	4.9	1.6	1.5	0	0	20.8	0	0	2.1	0	0.3	0	3.7	0.1	0	5.5	0.8	0.1	8.2	5.2	0	2.5	0	0	1.3	2.5	3.9	0	0	0.9	0	0	0	4.9	0	0	3.3	0	14.3	0.8	0	0	0.3	2.4	0	0	0	0.1	0	10.5	0	5.3	0.1	0.2	2.1	2.2	0	15.5	6.1	1.5	1.7	0	1.1	0	0	1.7	0	2	0	0	1.2	0.3	0	0	1	0	0.6	0	0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3	5.4	0.4	0	1.1	3.4	0	0	31.9	0.8	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	2.9	3.2	0	0	2.7	0.4	0.3	3.2	0	1	0	0.7	0	0	0	0	2.6	6.5	0.2	0.5	1.4	0	0	0	0	0	Bipolar cells
VSTM2A	MGC33530, VSTM2	ENSG00000170419	V-set and transmembrane domain containing 2A	Q8TAG5	7	54542325-54571080	Plasma proteins, Predicted secreted proteins	Differentiation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 13.7;brain: 51.7;prostate: 13.7	Cell type enriched	Detected in some	5	Bipolar cells: 38.3	Cancer enhanced	Detected in some		breast cancer: 4.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	Karpas-707: 3.4;SCLC-21H: 10.5;SH-SY5Y: 7.2	Low region specificity	Detected in all			Low region specificity	Detected in all								Secreted in other tissues								unprognostic (1.15e-1)		unprognostic (1.02e-1)		unprognostic (1.89e-1)						unprognostic (1.14e-2)	unprognostic (4.66e-1)	prognostic favorable (5.34e-4)	unprognostic (4.34e-2)	unprognostic (6.79e-2)		unprognostic (7.15e-2)	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6	1.4	0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3	0	0.7	0	0.7	0.9	0.3	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	1.1	0	0.2	0	0	0	0	0	10.5	7.2	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3	0	0	0	0	0	38.3	0.4	0	1.4	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	7	0	0	0	0.3	0	0	0	0	2.3	0	0	0	0	3.6	0	0	0.2	0.1	0	0	0	0	0	Bipolar cells
FNDC9	C5orf40, MGC27121	ENSG00000172568	Fibronectin type III domain containing 9	Q8TBE3	5	157341600-157345721	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	7	adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0	Cell type enriched	Detected in single	5	Bipolar cells: 3.4	Cancer enriched	Detected in single	16	glioma: 0.8	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6	Group enriched	Detected in many	5	basal ganglia: 21.9;hypothalamus: 28.4	Low region specificity	Detected in all			HPA011115	Uncertain											HPA011115: AB_1079374	unprognostic (2.35e-3)	unprognostic (3.80e-2)	unprognostic (2.93e-1)		unprognostic (3.53e-3)	unprognostic (4.90e-3)		unprognostic (3.40e-1)	unprognostic (1.95e-1)	unprognostic (1.68e-1)	unprognostic (2.10e-2)	unprognostic (1.86e-1)	unprognostic (6.35e-6)	unprognostic (3.63e-2)	unprognostic (6.39e-2)	unprognostic (1.57e-1)	unprognostic (1.12e-3)	0.6	9.4	3.9	1.5	21.1	2	0.6	9.1	24	0.5	1.1	0	0	0.6	0.6	0.9	0.5	0.6	0.6	0.7	1.9	22	0.7	0.6	0.5	0.9	1.3	3.8	0.5	0.5	0.5	10	0.6	5.8	0.6	1.2	0	0.5	0.6	0.6	0.6	0.8	0.8	1.3	0.6	0.6	0.5	0.4	0	0.6	0	0.5	0.6	0	0.5	0.3	0.8	0.8	0	1.9	0.1	0	0.2	0.4	0.4	0	0	0.4	1	0	0.2	0	0.2	0	1.7	0	0	0.1	0.1	0	0	0	0.1	0.1	0	1.8	0	0	0.4	0.8	0	0	0	0	1	0	0.5	0	3	0	0	0.9	0	0	0	0	0.3	0	0.3	0	0.2	0.4	0.1	0	0.3	0	0.9	0	0	0	0.6	1	0.3	0.3	1.6	0	1	0.4	0	0.1	0	0	0.8	1.9	0.2	0.1	0	0.6	1.3	0	0.5	0.8	1.5	0.2	0	0.8	0.3	0	0.1	3.9	21.1	9.1	13.3	1.9	22	1.3	3.8	5.8	0.4	0	0	0	0	0	3.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	Bipolar cells
ABCD2	ALDL1, ALDR, ALDRP	ENSG00000173208	ATP binding cassette subfamily D member 2	Q9UBJ2	12	39550033-39619751	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 24.1;brain: 30.1	Cell type enriched	Detected in some	6	Bipolar cells: 55.5	Cancer enriched	Detected in single	7	glioma: 1.9	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Lineage enriched	Detected in many	4	T-cells: 6.5	Group enriched	Detected in some	5	ASC diff: 9.2;HDLM-2: 12.4;Karpas-707: 22.2;SH-SY5Y: 13.4;U-266/70: 7.5	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.26e-3)	unprognostic (4.06e-4)	unprognostic (9.27e-2)	unprognostic (1.15e-2)	unprognostic (2.06e-1)	unprognostic (7.31e-5)	unprognostic (3.42e-2)	unprognostic (2.90e-2)	unprognostic (8.06e-3)	unprognostic (3.43e-2)	unprognostic (1.24e-2)	unprognostic (1.20e-1)	unprognostic (3.47e-4)	unprognostic (5.04e-2)	unprognostic (8.04e-2)	unprognostic (1.13e-1)	unprognostic (6.74e-2)	24.1	3.6	6.8	3.5	6.8	0.9	5.5	30.1	13.4	10.6	1.7	1.3	0	1.4	5.4	1	1.3	5.2	1.4	7.4	5.1	4.1	1.4	0.7	1.4	4.8	4.8	8.4	0.7	0.7	0.7	5.1	0.5	11.4	1.2	1.7	2.9	4.6	1.6	0.7	0.7	1.7	5.1	2.1	3	1.6	0.9	2.6	0.9	1	0.6	3.2	2.8	1.9	0.8	0.8	0.1	0	1.4	6.5	1.8	0	0	0.1	0	9.2	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	12.4	0	0.1	0	0	0.4	0.1	0	2.3	0	0	0	0	0	0	0	22.2	0	0	0.2	0	0	0	0	0.1	0	1.2	0	0	0	13.4	0	0	0	0	0	0.3	0	0	0	0	0	7.5	0.9	0.1	0	0.2	0	0	0	0	2.4	0	1.9	0.8	4.3	5.7	0.2	0.4	5	6.5	0.1	1.4	0	0.8	5.1	1.8	6.8	6.8	30.1	13.4	5.1	4.1	4.8	8.4	11.4	2.6	0	0	0.8	0	0	55.5	8.9	0	4	0	0	5.9	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	1.8	0	1.7	0	0	0.7	0.5	1.8	0	0.3	0.1	0	0	0	3.5	0	0	Bipolar cells
TMEM196	MGC42090	ENSG00000173452	Transmembrane protein 196	Q5HYL7	7	19719310-19773598	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 15.0;pituitary gland: 12.6	Cell type enriched	Detected in some	10	Bipolar cells: 51.1	Cancer enhanced	Detected in single		glioma: 0.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	ASC diff: 8.8;ASC TERT1: 8.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043163	Uncertain		Uncertain	Nucleoplasm,Golgi apparatus	Intracellular and membrane					Nucleoplasm, Golgi apparatus		HPA043163: AB_10794772					unprognostic (6.08e-3)					unprognostic (1.88e-2)	unprognostic (2.14e-2)		unprognostic (9.30e-2)	unprognostic (5.63e-2)				0.7	3.7	8	0.6	8.6	0.4	0.4	0.3	15	1.2	0.6	0.3	0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3	0.7	12.6	0.4	5	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1	1.4	0.4	2.6	0.5	2.8	0	0.4	0	0.4	0.4	0.1	0	0	0	0	0	0	0	0	0	0.8	0	8.8	8.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5	2.8	0	0	0	0	0	51.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	3.2	0	0	0	0	2.6	0	0	0	0	1.8	0.4	0	0	0	5.3	0	0	0	0	0	0	0	0	0	Bipolar cells
VWC2L		ENSG00000174453	Von Willebrand factor C domain containing protein 2 like	B2RUY7	2	214411065-214578959	Predicted secreted proteins		Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	brain: 8.9;pituitary gland: 2.3	Cell type enriched	Detected in single	9	Bipolar cells: 3.4	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		AF22: 1.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA044815, HPA059414	Uncertain				Secreted - unknown location							HPA044815: AB_10962359, HPA059414: AB_2684007	unprognostic (8.77e-2)				unprognostic (2.83e-3)			unprognostic (2.05e-2)		unprognostic (8.49e-2)	unprognostic (1.51e-3)	unprognostic (4.36e-1)	unprognostic (2.56e-2)	unprognostic (2.05e-1)		unprognostic (3.89e-1)		0.3	0.3	1.9	0.3	3.2	0.3	0.3	0.2	8.9	0.3	0.3	0	0	0.3	0.3	0.5	0.3	0.4	0.3	0.3	2.4	6.6	0.3	0.3	0.5	0.3	3.9	2.9	0.3	0.3	0.3	2.3	0.3	6.6	0.4	0.3	0.1	0.3	0.4	0.5	0.4	0.3	0.3	1	0.3	0.4	0.5	0	0	0.3	0	0.3	0.3	0	0	0	0	0	0	0.2	0	0	0	1.1	0	0	0	0	0	0.3	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.9	3.2	0.2	8.5	2.4	6.6	3.9	2.9	6.6	0	0	0	0	0	0	3.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Bipolar cells
SLITRK1	KIAA1910, LRRC12	ENSG00000178235	SLIT and NTRK like family member 1	Q96PX8	13	83877205-83882393	Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	10	brain: 30.6	Cell type enriched	Detected in some	6	Bipolar cells: 6.6	Cancer enriched	Detected in single	8	glioma: 1.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA074835	Enhanced				Secreted in brain				270000			HPA074835: 	unprognostic (2.29e-1)				unprognostic (4.32e-1)					unprognostic (4.71e-2)	unprognostic (1.01e-1)			unprognostic (1.65e-2)	unprognostic (7.95e-2)			0.9	1.3	16.7	0.9	9.5	0.9	1	2	30.6	1.2	1	6.3	0	1	1	1	0.9	0.9	1	0.9	16.9	7.3	1	0.9	0.9	0.9	7.3	14.9	0.9	3.1	0.9	3.1	0.9	5.8	0.9	1	0.1	1	1.4	1	0.9	0.9	0.9	3.7	0.9	1	1	8.5	0	0.9	0	0.9	0.9	0.2	0	0	0	0	0	0	0	7.6	0	3.2	0	0.1	0.8	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.6	2.8	0	0	0	0.7	0	0	0	0	0.8	0	0	0.7	0	0	0	0	0	0	0.1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.7	9.5	2	21.5	16.9	7.3	7.3	14.9	5.8	8.5	0	0	0	0	0	6.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	1	0	0	0	0	0	0	0	0	0	Bipolar cells
BHLHE22	Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20	ENSG00000180828	Basic helix-loop-helix family member e22	Q8NFJ8	8	64580367-64583628	Predicted intracellular proteins, Transcription factors	Neurogenesis, Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	brain: 30.7	Cell type enriched	Detected in some	5	Bipolar cells: 28.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	23	THP-1: 41.9	Group enriched	Detected in many	5	amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8	Group enriched	Detected in all	8	amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6	HPA064128, HPA064872, HPA067500	Enhanced											HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855	unprognostic (9.17e-2)	unprognostic (1.11e-2)	unprognostic (5.44e-2)	unprognostic (2.28e-5)	unprognostic (7.22e-3)	unprognostic (6.47e-4)	unprognostic (2.41e-1)	unprognostic (1.08e-1)	unprognostic (1.30e-1)	unprognostic (6.58e-2)	unprognostic (1.52e-1)	unprognostic (3.71e-2)	unprognostic (2.86e-7)	unprognostic (3.20e-2)	unprognostic (2.29e-1)	unprognostic (6.72e-3)	unprognostic (1.86e-1)	2.9	1.3	30.7	2.9	1.4	0.3	1.7	21.1	15.8	1.7	1.7	1.2	0.3	1.1	0.5	0.4	2.2	0.6	1.1	0.8	27.2	2.1	0.5	1.3	1.4	2.4	1.7	6.5	0.4	1.3	0.5	1.2	0.2	3.4	0.5	1.4	2.5	1.2	5.4	0.5	0.8	1.7	1.1	2.6	2.9	1.1	0.7	0.2	0	0.6	0	1.3	2.5	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	41.9	0	0	0	0	0	0.6	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.7	1.4	21.1	10.6	27.2	2.1	1.7	6.5	3.4	0.2	0	0	0	0	1	28.7	0.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	3.1	0	0	1	0	1.3	0	0	0.4	0	2.5	0	6.2	0	0	1.4	0	0	0	0	Bipolar cells
HS3ST4	3OST4	ENSG00000182601	Heparan sulfate-glucosamine 3-sulfotransferase 4	Q9Y661	16	25692026-26137688	Enzymes, Predicted membrane proteins		Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	brain: 23.9	Cell type enriched	Detected in single	8	Bipolar cells: 5.8	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 5.5;SCLC-21H: 2.3;SuSa: 1.5	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (1.09e-2)	unprognostic (1.87e-1)	unprognostic (2.95e-1)		unprognostic (2.24e-1)	unprognostic (1.43e-3)		unprognostic (1.27e-1)		unprognostic (3.84e-1)	unprognostic (8.81e-3)	unprognostic (6.71e-2)		unprognostic (2.39e-1)	unprognostic (1.92e-1)	unprognostic (2.51e-2)	unprognostic (3.67e-2)	0.7	0.8	6.9	0.6	9.3	0.6	5.1	6.8	23.9	1.1	0.6	2.6	0	0.6	0.7	1.3	0.9	0.7	0.6	0.6	11.5	10	0.7	0.6	0.6	0.6	5.9	10.8	0.7	0.6	0.6	0.1	0.6	14.3	2	0.6	0.3	0.8	0.6	0.6	0.7	0.6	0.6	2.2	3.7	1.1	1.3	1.5	0	0.6	0	0.8	1	0.2	0.1	0	0.1	0	0.1	0	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	5.5	0	0	0	0	0	0	0	2.3	0	0	0	0.1	1.5	0	0	0.1	0	0.8	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	6.9	9.3	6.8	13.4	11.5	10	5.9	10.8	14.3	1.5	0	0	0	0.4	0	5.8	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.1	Bipolar cells
NYX	CLRP, CSNB1, CSNB1A, CSNB4	ENSG00000188937	Nyctalopin	Q9GZU5	X	41447434-41475710	Disease related genes, Predicted intracellular proteins	Sensory transduction, Vision		Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	retina: 13.9	Cell type enriched	Detected in some	8	Bipolar cells: 13.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HDLM-2: 7.4;NTERA-2: 1.9	Not detected	Not detected			Low region specificity	Detected in single								Intracellular and membrane											unprognostic (3.27e-2)	unprognostic (6.72e-2)				unprognostic (4.21e-2)	unprognostic (4.10e-4)			unprognostic (1.83e-1)	unprognostic (3.96e-2)	unprognostic (1.80e-1)			0	0	0.1	0	0.4	0	0	0	0.7	0	0	0.4	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0	0	0	0.4	0	0.1	0.3	0	0	13.9	0	0.2	0	0	0	0	0	0.3	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0.4	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0.7	0	0	0.1	0	0.3	0	0	0	0	0	0	13.9	0.4	0	0	0	1.8	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.5	0	0	0.5	1.1	0	0.2	0	0	0	Bipolar cells
DOK6	DOK5L, HsT3226, MGC20785	ENSG00000206052	Docking protein 6	Q6PKX4	18	69401055-69849087	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.1	Cell type enriched	Detected in some	7	Bipolar cells: 239.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.5;SCLC-21H: 4.8;SH-SY5Y: 10.9;SuSa: 8.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041099, HPA063534	Approved		Approved	Focal adhesion sites,Cytosol						Focal adhesion sites, Cytosol		HPA041099: AB_2677299, HPA063534: AB_2685032	unprognostic (5.83e-2)	unprognostic (1.39e-1)	unprognostic (2.06e-1)	unprognostic (1.21e-1)	unprognostic (2.77e-2)	unprognostic (2.59e-1)	unprognostic (1.55e-1)	unprognostic (1.90e-2)	unprognostic (8.62e-2)	unprognostic (5.99e-2)	unprognostic (1.04e-2)	unprognostic (4.60e-3)	unprognostic (2.13e-4)	unprognostic (2.30e-3)	unprognostic (2.88e-2)	unprognostic (4.49e-3)	unprognostic (1.09e-3)	2.1	1.6	21.3	1.6	11.3	0.6	1.3	6.8	22.1	3.8	1.5	0.9	0.3	1	3	1.4	1.7	1.7	5.8	10.2	19.2	9.2	8.7	4.4	4.2	1.2	13.7	13.1	4.2	0.7	3.4	1.1	9.9	14	3.5	1.3	5.5	1.7	4.2	0.6	1.2	1.3	6.6	2.7	1.8	1.3	2.8	2.7	0	4.1	0	1.2	5.2	6.6	0	0	0	0	0.9	0.9	0.4	0	0	2.7	0	0	0	0	0.1	0.4	0	0	0	0	0.2	0	10.4	0	0	0	0	0	0	1.2	1	0	10.9	0.3	0	0.2	0.8	0	0	0	0.1	0	0	0	0	0	0	0	0	1.7	0	0	0	0	10.5	0	0	4.8	10.9	0	0	0	8.1	0	0	0	4.1	0.6	0	1.5	0.3	0	0	3.1	0	3.2	0	0	0	0.9	0	0.6	0	0.2	0.4	0	0	0.1	0.5	0	0.9	0	0	0.3	0.4	21.3	11.3	6.8	17.1	19.2	9.2	13.7	13.1	14	2.7	0	0	0	0.1	0.2	239.6	6.5	0	0	2.3	0	13.7	0	1.7	0	32.5	0.7	0	0	0	0	5.3	0.1	0	1	0	9.5	0	0	0.3	23	1.4	0.3	0	0	0	4.1	0	0	6.3	7.8	12.7	0	2.7	0.7	0.1	0.5	0	0	0	0.1	Bipolar cells
CPLX3	CPX-III	ENSG00000213578	Complexin 3	Q8WVH0	15	74826547-74831802	Predicted intracellular proteins	Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8	Cell type enriched	Detected in some	7	Bipolar cells: 506.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 5.6;Karpas-707: 4.9;SCLC-21H: 2.2;SK-BR-3: 2.8;U-266/84: 3.2;U-698: 2.3	Low region specificity	Detected in some			Low region specificity	Detected in many			CAB079003		Supported										CAB079003: 																		0.4	2.5	6.4	0.5	7.4	0.4	0.4	20.8	19.6	0.5	0.5	3.3	0	0.4	0.4	0.5	0.5	0.4	0.4	13.4	6.4	0.8	0.4	0.4	0.4	0.5	0.6	7.9	0.4	0.4	0.4	1.7	0.4	8.2	56.4	0.4	32.8	9.8	0.4	0.4	0.5	0.6	0.4	1	31.8	4.6	2.2	1.2	0	0.4	0	0.5	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	1.5	0	0	0.1	0.2	0.1	0	5.6	0.1	0	0	0.2	0.1	0	0	1.9	0.1	0	0.1	0	0	0	1.2	0	0.2	0.2	0	0	0	0.3	0	4.9	0	0.1	0	0.9	0.1	0	0.3	0.2	0	0.4	0	0.1	2.2	0.1	0	2.8	1.2	0.3	1.7	0	0	0.1	0.1	0.5	0	1.4	3.2	2.3	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	7.4	20.8	19.6	6.4	0.8	0.6	7.9	8.2	1.2	0	0	0	0.2	0	506.7	0	0	0	0	0	72.6	0	0	0	2.2	0	0	0	0	0	0	11.9	0	0	0	14.3	0	0	0	2.7	0	0	0	0	0	10.5	0	0	0	0	54.1	0	0	8.1	1.7	0	0	0	0	0.1	Bipolar cells
LACTBL1		ENSG00000215906	Lactamase beta like 1	A8MY62	1	22953043-22965338	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	17	testis: 2.2	Cell type enriched	Detected in single	7	Bipolar cells: 2.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	Hep G2: 3.1	Not detected	Not detected			Not detected	Not detected			HPA066810			Approved	Nuclear bodies						Nuclear bodies		HPA066810: 																		0	0	0	0.1	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	2.2			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	2.6	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	Bipolar cells
LINGO3	LERN2, LRRN6B	ENSG00000220008	Leucine rich repeat and Ig domain containing 3	P0C6S8	19	2289784-2292024	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 6.9;brain: 15.7;lymphoid tissue: 7.1	Cell type enriched	Detected in some	7	Bipolar cells: 32.9	Cancer enhanced	Detected in some		glioma: 1.4					Cell type enhanced	Detected in some		eosinophil: 6.9	Lineage enriched	Detected in many	7	granulocytes: 6.9	Cell line enriched	Detected in some	4	HMC-1: 19.7	Low region specificity	Detected in many			Group enriched	Detected in all	7	basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5	HPA043781, HPA059558	Enhanced		Approved	Mitochondria						Mitochondria		HPA043781: AB_2678668, HPA059558: AB_2684062	unprognostic (1.24e-1)	unprognostic (1.00e-1)	unprognostic (7.16e-3)	unprognostic (3.10e-1)	unprognostic (1.59e-1)	unprognostic (3.61e-3)	unprognostic (3.53e-1)	unprognostic (7.45e-3)	unprognostic (1.11e-2)	unprognostic (3.19e-2)	unprognostic (4.03e-4)	unprognostic (2.35e-2)	unprognostic (1.36e-2)	unprognostic (1.79e-1)	unprognostic (5.74e-2)	unprognostic (1.05e-1)	unprognostic (4.14e-2)	0.1	0.2	2.2	3.1	15.7	2.8	0	4.6	2.9	0	0.4			0.5	0	0	0	0	0	0	1.9	1.2	0	0	0.2	2.7	1.2		0	0	0	0	0		0	0		0.1	0	0.3	0.1	1.2	0	0.4	7.1	1.2	0.1			0		0	0	0	1	0.1	6.9	0.1	0.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0.8	0	0.8	0	0	0	2.1	19.7	0	0	0	0	0	0	0	0.2	0.6	0	0	0	2.6	0.2	0	0.1	1.9	0	4.8	0	0	0.7	0.2	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0.1	0	1.9	0	1.9	0.1	6.9	0.4	0	0.4	0.5	0	0.2	0.1	1	0.1	0	2.9	0.3	0.1	0	0.6	0											0	0	0	0	0.1	32.9	0.6	0	0	0	0	3.9	0	0	0	0.4	0	0	0	0	0.1	0	0	4.6	0	0.2	3.2	0	0	2.1	0	0	0.2	0	1.8	0	0.1	0	0	0	0	1.8	0	0	0.3	0.9	0	0	0	0	0	Bipolar cells
TRNP1	C1orf225, LOC388610	ENSG00000253368	TMF1-regulated nuclear protein 1	Q6NT89	1	26993707-27000898	Predicted intracellular proteins	Cell cycle, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		stomach 1: 81.1	Cell type enriched	Detected in many	12	Bipolar cells: 375.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	9	intermediate monocyte: 2.8;non-classical monocyte: 1.7	Lineage enriched	Detected in single	12	monocytes: 2.8	Cell line enhanced	Detected in many		ASC TERT1: 46.9;BJ hTERT+: 44.5;EFO-21: 37.6;RPTEC TERT1: 37.5	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.41e-1)	unprognostic (7.15e-2)	unprognostic (7.70e-2)	unprognostic (1.15e-1)	unprognostic (2.88e-3)	unprognostic (6.23e-2)	prognostic unfavorable (1.90e-6)	unprognostic (3.53e-1)	unprognostic (8.39e-3)	unprognostic (1.64e-1)	unprognostic (1.90e-1)	unprognostic (9.71e-3)	prognostic unfavorable (7.72e-4)	unprognostic (1.55e-1)	unprognostic (5.56e-2)	unprognostic (1.88e-1)	unprognostic (2.55e-2)	4.1	4.3	11.3	2	11.7	0.9	8.5	12.3	22	6.3	5.3	1.8	0.5	3.7	6.8	3.7	32	7.9	20.9	11.6	9.7	10.2	9.3	2.6	5.1	2.3	10.1	9.2	3.6	13.2	12.9	5.3	5.8	18.4	5.9	2.6	9.6	6	8.1	1.6	4.2	3.7	7.8	2.8	3	81.1	2.1	1.7	0.1	2.8	2.4	16.2	9.1	9.3	0	0.2	0	2.8	0	0	0	6.3	18.7	4.6	2.9	36.2	46.9	0	32.7	44.5	3	1.4	2.5	3.1	0	37.6	30.4	1.2	6.6	2.4	13.2	3.7	0.1	1.9	0	0.4	13	26.2	0	0	26.8	28.1	1.5	28.9	2.9	2.9	0.2	0.4	0	7.2	0.9	0	0.4	6	28.7	31	1.8	0	0.5	37.5	1.9	7.7	0.5	6.3	1.3	14.9	3	0.6	0.1	15.3	1	7.5	16	1.4	0	0.1	0.1	1	0.1	1.8	0	0.1	0	0	2.8	0	0	0	0	0.2	0	0	0	0	0	1.7	0	0	0	11.3	11.7	12.3	22	9.7	10.2	10.1	9.2	18.4	1.7	17.9	1.1	0	10.1	6.5	375.7	21.9	30.6	2.7	3.4	8.7	7.9	0.1	26.6	6.9	0.4	1	0	0	27.2	0.1	1.4	4	0	0.2	0.2	7.9	11.5	1.8	1.9	0	8.9	0.8	3.3	1.8	0.5	27.5	20.3	0	2.8	0	31.8	25.8	13.3	1.4	0.5	7.8	0	0	0.2	9.5	Bipolar cells
GPR179	CSNB1E, GPR158L1	ENSG00000277399	G protein-coupled receptor 179		17	38325530-38343847	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		brain: 3.0;retina: 7.5	Cell type enriched	Detected in some	13	Bipolar cells: 24.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.0;U-266/84: 1.1	Not detected	Not detected			Low region specificity	Detected in many			HPA017885	Uncertain											HPA017885: AB_2279357	unprognostic (1.65e-1)	unprognostic (2.27e-1)	unprognostic (1.24e-4)	unprognostic (8.89e-3)	unprognostic (1.34e-1)	unprognostic (1.09e-1)	unprognostic (2.10e-1)	unprognostic (3.04e-2)	unprognostic (4.76e-2)	unprognostic (2.34e-2)	unprognostic (6.57e-3)	unprognostic (5.31e-2)	unprognostic (5.09e-10)	unprognostic (6.18e-2)	unprognostic (2.31e-1)	unprognostic (1.62e-2)	unprognostic (3.41e-4)	0.2	0.6	1.6	0	3	0	0.2	0.8	1.9	0.1	0.1	0.2	0	0.3	0.2	1	0	0.2	0	0	0.5		0	0.1	0.2	0	0	0.3	0	0	0	0	0.1	1.4	0.3	0	7.5	0.6	0.3	1.5	0	0.3	0.1	0.6	0	0.5	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.2	0	1	0.3	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0.7	0.2	0	0	0	0	0	0.2	0.4	0.5	0.1	0	0	0	0.5	0	0.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0.2	0.1	0.1	0.1	0	0	0.4	0	0	0	1.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0											0	0	0	0	0	24.9	0.6	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	Bipolar cells
